Document:

EX-4.5

 Exhibit 4.5 

PERIPHAS CAPITAL PARTNERING CORPORATION 

DESCRIPTION OF SECURITIES 

The following summary of the material terms of the securities of Periphas Capital Partnering Corporation is not intended to be a complete
summary of the rights and preferences of such securities and is subject to and qualified by reference to our amended and restated certificate of incorporation and bylaws incorporated by reference as an exhibit to the company’s Annual Report on
Form 10-K for the year ended December 31, 2020 (the “Report”), and applicable Delaware law. We urge you to read our amended and restated certificate of incorporation and bylaws of association in
their entirety for a complete description of the rights and preferences of our securities. 
 Certain Terms 

Unless otherwise stated in this exhibit or the context otherwise requires, references to: 

 

	 	•	 	 “amended and restated certificate of incorporation” are to our certificate of incorporation in effect
as of December 11, 2020; 

  

	 	•	 	 “anchor investors” are to certain qualified institutional buyers or institutional accredited
investors, each of which became a member of our sponsor upon the consummation of our initial public offering and expressed to us an interest to purchase CAPSTM in our initial public offering,
as further described herein; 

  

	 	•	 	 “Board” are to our board of directors; 

 

	 	•	 	 “Class A shares” are to our shares of Class A common stock, par value $0.0001 per share;

  

	 	•	 	 “Class B shares” are to our shares of Class B common stock, par value $0.0001 per share;

  

	 	•	 	 “Class F shares” are to our shares of Class F common stock, par value $0.0001 per share;

  

	 	•	 	 “common stock” are to our Class A common stock, Class B common stock, and our Class F
common stock; 

  

	 	•	 	 “directors” are to our current directors and director nominees; 

 

	 	•	 	 “equity-linked securities” are to any debt or equity securities that are convertible, exercisable or
exchangeable for shares of our Class A common stock issued in a financing transaction in connection with our partnering transaction, including but not limited to a private placement of such securities; 

	 	•	 	 “forward purchase agreements” are to the agreements providing for the sale of the forward purchase
shares to the anchor investors in private placements, dated December 9, 2020; 

  

	 	•	 	 “forward purchase shares” are to the shares of Class A common stock to be issued pursuant to the
forward purchase agreements; 

  

	 	•	 	 “founder shares” are to our Class F shares and our Class A shares issued upon the automatic
conversion thereof at the time of our partnering transaction as provided herein; 

  

	 	•	 	 “initial stockholders” are to our sponsor and any other holders of our founder shares immediately prior
to our initial public offering; 

  

	 	•	 	 “letter agreement” refers to the letter agreement dated December 9, 2020 among the Periphas
Capital Partnering Corporation, PCPC Holdings, LLC, and each executive officer and director; 

  

	 	•	 	 “management” or our “management team” are to our officers; 

 

	 	•	 	 “operating partners” are to Brian Clingen, Eric Foss, Fred Buttrell, Gerald Rittenberg and
Dr. William Joyce; 

  

	 	•	 	 “partnering transaction” are to effectuating a merger, share exchange, asset acquisition, share
purchase, reorganization or similar partnering transaction with one or more businesses which may be held by one or more third-party sponsors; 

  

	 	•	 	 “performance shares” are to our Class B shares issued to our sponsor; 

 

	 	•	 	 “Periphas Capital” are to Periphas Capital, LP; 

 

	 	•	 	 “permitted withdrawals” are to the withdrawals permitted to be made by us from the trust account to pay
taxes including income and franchise taxes and to withdraw up $100,000 in dissolution expenses in the event we do not complete a partnering transaction within 24 months (or 27 months, as applicable); 

 

	 	•	 	 “private placement CAPSTM” are to the private
placement shares and warrants issued to our sponsor in a private placement simultaneously with the closing of our initial public offering and upon conversion of working capital loans, if any, which private placement CAPSTM are identical to the CAPSTM sold in our initial public offering, subject to certain limited exceptions as described in this exhibit;

  

	 	•	 	 “private placement shares” are to the shares of Class A common stock sold as part of the private
placement CAPSTM; 

  
 2 

	 	•	 	 “private placement warrants” are to the warrants sold as part of the private placement CAPSTM; 

  

	 	•	 	 “public shares” are to the shares of our Class A common stock sold as part of the CAPSTM in our initial public offering (whether they are purchased in our initial public offering or thereafter in the open market); 

 

	 	•	 	 “public stockholders” are to the holders of our public shares, including our sponsor, officers and
directors to the extent our sponsor, officers or directors purchase public shares, provided that each of his, her or its status as a “public stockholder” shall only exist with respect to such public shares; 

 

	 	•	 	 “sponsor” are to PCPC Holdings, LLC, a Delaware limited liability company; 

 

	 	•	 	 “warrants” are to our warrants sold as part of the
CAPSTM in our initial public offering (whether they are purchased in our initial public offering or thereafter in the open market) and as part of the private placement CAPSTM; and 

  

	 	•	 	 “we,” “us,” “our”, “the company” and “PCPC” are to Periphas
Capital Partnering Corporation, a Delaware corporation. 

 We are a Delaware corporation and our affairs are governed by
our amended and restated certificate of incorporation and Delaware General Corporation Law ( the “DGCL”). Pursuant to our amended and restated certificate of incorporation which was adopted prior to the consummation of our initial public
offering, we are authorized to issue 431,000,000 shares of common stock, $0.0001 par value each, including 380,000,000 shares of Class A common stock, 1,000,000 shares of Class B common stock, and 50,000,000 shares of Class F common
stock, as well as 1,000,000 shares of preferred stock, $0.0001 par value each. The following description summarizes certain terms of our capital stock as set out more particularly in our amended and restated certificate of incorporation. Because it
is only a summary, it may not contain all the information that is important to you. 
 CAPSTM

 Each CAPSTM has an offering price of $25.00 and consists of one share of
Class A common stock and one-fourth of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one share of Class A common stock at a price of $28.75 per share,
subject to adjustment as discussed below. Pursuant to the warrant agreement, a warrant holder may exercise its warrants only for a whole number of the shares of Company’s Class A common stock. This means only a whole warrant may be
exercised at any given time by a warrant holder. For example, if a warrant holder holds one-fourth, one-half or three-quarters of one warrant to purchase
a share of Class A common stock, such warrant will not be exercisable. If a warrant holder holds two-halves of one warrant, such whole warrant will be exercisable for one share of Class A
common stock at a price of $28.75 per share. The Class A common stock and warrants comprising the units began trading on December 15, 2020. Holders will have the option to 

  
 3 

 
continue to hold CAPSTM or separate their CAPSTM into the component securities.
Holders will need to have their brokers contact our transfer agent in order to separate the CAPSTM into shares of Class A common stock and warrants. No fractional warrants will be issued
upon separation of the CAPSTM and only whole warrants will trade. Accordingly, unless you purchase at least four CAPSTM, you will not be
able to receive or trade a whole warrant. 
 Private Placement CAPSTM 

The private placement CAPSTM (including the private placement shares, the private
placement warrants and shares of Class A Common Stock issuable upon exercise of such warrants) will not be transferable or salable until 30 days after the completion of our initial partnering transaction business (except, among other limited
exceptions) and the private placement warrants included therein will not be redeemable by us so long as they are held by our sponsor or its permitted transferees. Holders of our private placement
CAPSTM are entitled to certain registration rights. If we do not consummate a partnering transaction within 24 months (or 27 months, as applicable) from the closing of our initial public
offering, the proceeds from the sale of the private placement CAPSTM held in the trust account will be used to fund the redemption of our public shares (subject to the requirements of
applicable law) and the private placement CAPSTM (and the underlying securities) will expire worthless. Further, if we seek shareholder approval, we will complete our partnering transaction
only if a majority of the common stock, represented in person or by proxy and entitled to vote thereon, voted at a shareholder meeting are voted in favor of the partnering transaction. In such case, our sponsor and each member of our management team
have agreed to vote their founder shares, performance shares, private placement shares and any public shares purchased during or after our initial public offering in favor of our initial partnering transaction. Otherwise, the private placement CAPSTM are identical to the CAPSTM sold in our initial public offering. 

Common Stock 
 Prior to the closing of our
initial public offering, there were 828,000 founder shares outstanding (after giving effect to a forward stock split effected December 11, 2020, that increased the number of outstanding founder shares from 690,000 to 828,000 shares), all of
which were held of record by our initial stockholders, so that our initial stockholders would own 5% of the outstanding Class A shares issued in our initial public offering (not including the private placement shares) after our initial public
offering. Upon the closing of our initial public offering, 17,753,600 of our shares of common stock are outstanding including: 
  

	 	•	 	 16,560,000 shares of Class A common stock underlying
CAPSTM issued as part of our initial public offering; 

  

	 	•	 	 245,600 shares of Class A common stock underlying the private placement CAPSTM; 

  

	 	•	 	 120,000 performance shares; and 

 

	 	•	 	 828,000 founder shares held by our initial stockholders. 

  
 4 

 Stockholders of record are entitled to one vote for each share held on all matters to be
voted on by stockholders. Holders of shares of Class A common stock, holders of shares of Class B common stock and holders of shares of Class F common stock will vote together as a single class on all matters submitted to a vote of
our stockholders except as required by law. Holders of performance shares are entitled to vote together with the holders of all other classes of common stock in the election of directors. Unless specified in our amended and restated certificate of
incorporation, or as required by applicable provisions of the DGCL or applicable stock exchange rules, the affirmative vote of a majority of our shares of common stock that are voted is required to approve any such matter voted on by our
stockholders. In addition, pursuant to our amended and restated certificate of incorporation, the powers, preferences or relative, participating, optional or other special rights of the performance shares or the founder shares, as applicable, may be
amended only with the prior vote or written consent of the holders of a majority of the performance shares or the founder shares then outstanding, as applicable, voting separately as a single class. Our board of directors is divided into three
classes, each of which will generally serve for a term of three years with only one class of directors being elected in each year. There is no cumulative voting with respect to the election of directors, with the result that the holders of more than
50% of the shares voted for the election of directors can elect all of the directors. Our stockholders are entitled to receive ratable dividends when, as and if declared by the board of directors out of funds legally available therefor. 

Because our amended and restated certificate of incorporation authorizes the issuance of up to 380,000,000 shares of Class A common
stock, if we were to enter into a partnering transaction, we may (depending on the terms of such a partnering transaction) be required to increase the number of shares of Class A common stock which we are authorized to issue at the same time as
our stockholders vote on the partnering transaction to the extent we seek stockholder approval in connection with our partnering transaction. 

Our board of directors is divided into three classes with only one class of directors being elected in each year and each class (except for
those directors appointed prior to our first annual meeting of stockholders) serving a three-year term. 
 In accordance with the New York
Stock Exchange’s (the “NYSE”) corporate governance requirements, we are not required to hold an annual meeting until no later than one year after our first full fiscal year end following our listing on the NYSE. Under
Section 211(b) of the DGCL, we are, however, required to hold an annual meeting of stockholders for the purposes of electing directors in accordance with our bylaws, unless such election is made by written consent in lieu of such a meeting. We
may not hold an annual meeting of stockholders to elect new directors prior to the consummation of our partnering transaction, and thus we may not be in compliance with Section 211(b) of the DGCL, which requires an annual meeting. Therefore, if
our stockholders want us to hold an annual meeting prior to the consummation of our partnering transaction, they may attempt to force us to hold one by submitting an application to the Delaware Court of Chancery in accordance with
Section 211(c) of the DGCL. 
 We will provide our public stockholders with the opportunity to redeem all or a portion of their public
shares upon the completion of our partnering transaction at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account calculated as of two business days
prior to the consummation of our partnering transaction, including interest earned 

  
 5 

 
on the funds held in the trust account (net of permitted withdrawals and up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, subject
to the limitations described herein. The amount in the trust account is initially anticipated to be $25.00 per public share. Our sponsor, officers and directors have entered into a letter agreement with us, pursuant to which they have agreed to
waive their redemption rights with respect to any founder shares and public shares they hold in connection with the completion of our partnering transaction. Unlike many special purpose acquisition companies that hold stockholder votes and conduct
proxy solicitations in conjunction with their partnering transactions and provide for related redemptions of public shares for cash upon completion of such partnering transactions even when a vote is not required by law, if a stockholder vote is not
required by law and we do not decide to hold a stockholder vote for business or other legal reasons, we will, pursuant to our amended and restated certificate of incorporation, conduct the redemptions pursuant to the tender offer rules of the Unites
States Securities and Exchange Commission, (the “SEC”), and file tender offer documents with the SEC prior to completing our partnering transaction. Our amended and restated certificate of incorporation requires these tender offer
documents to contain substantially the same financial and other information about our partnering transaction and the redemption rights as is required under the SEC’s proxy rules. If, however, a stockholder approval of the transaction is
required by law, or we decide to obtain stockholder approval for business or other legal reasons, we will, like many special purpose acquisition companies, offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules
and not pursuant to the tender offer rules. If we seek stockholder approval, we will complete our partnering transaction only if a majority of the shares of common stock voted are voted in favor of our partnering transaction. However, the
participation of our sponsor, officers, directors, advisors, operating partners or their affiliates in privately-negotiated transactions (as described in the final prospectus related to our initial public offering), if any, could result in the
approval of our partnering transaction even if a majority of our public stockholders vote, or indicate their intention to vote, against such partnering transaction. For purposes of seeking approval of the majority of our outstanding shares of common
stock, non-votes will have no effect on the approval of our partnering transaction once a quorum is obtained. 

If we seek stockholder approval of our partnering transaction and we do not conduct redemptions in connection with our partnering transaction
pursuant to the tender offer rules, our amended and restated certificate of incorporation provides that a public stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a
“group” (as defined under Section 13 of the Exchange Act), will be restricted from seeking redemption rights with respect to more than an aggregate of 15% of the shares sold in our initial public offering without our prior consent,
which we refer to as the “Excess Shares,” without our prior consent. However, we would not be restricting our stockholders’ ability to vote all of their shares (including Excess Shares) for or against our partnering transaction. Our
stockholders’ inability to redeem the Excess Shares will reduce their influence over our ability to complete our partnering transaction, and such stockholders could suffer a material loss in their investment if they sell such Excess Shares on
the open market. Additionally, such stockholders will not receive redemption distributions with respect to the Excess Shares if we complete our partnering transaction. And, as a result, such stockholders will continue to hold that number of shares
exceeding 15% and, in order to dispose such shares would be required to sell their shares in open market transactions, potentially at a loss. 

  
 6 

 If we seek stockholder approval in connection with our partnering transaction, our sponsor,
officers and directors have agreed to vote any founder shares and performance shares they hold and any public shares purchased during or after our initial public offering in favor of our partnering transaction. As a result, in addition to the
founder shares, private placement shares and the performance shares, we would need 6,087,201, or 36.8%, of the 16,560,000 public shares sold in our initial public offering to be voted in favor of a partnering transaction in order to have our
partnering transaction approved (assuming all outstanding shares are voted). Additionally, each public stockholder may elect to redeem their public shares irrespective of whether they vote for or against the proposed transaction. 

Pursuant to our amended and restated certificate of incorporation, if we do not complete our partnering transaction within 24 months (or 27
months, as applicable) from the closing of our initial public offering (or such later date as approved by holders of a majority of the voting power of shares of our outstanding common stock that are voted at a meeting to extend such date, voting
together as a single class), we will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest earned on the funds held in the trust account (net of permitted withdrawals and up
to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further
liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining stockholders and our board of directors, liquidate and dissolve, subject in each case to our
obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. Our initial stockholders have entered into agreements with us, pursuant to which they have agreed to waive their rights to liquidating
distributions from the trust account with respect to their founder shares if we fail to complete our partnering transaction within 24 months (or 27 months, as applicable) from the closing of our initial public offering. However, if our initial
stockholders or management team acquire public shares in or after our initial public offering, they will be entitled to liquidating distributions from the trust account with respect to such public shares if we fail to complete our partnering
transaction within the prescribed time period. 
 In the event of a liquidation, dissolution or winding up of the company after a partnering
transaction, our stockholders are entitled to share ratably in all assets remaining available for distribution to them after payment of liabilities and after provision is made for each class of shares, if any, having preference over the common
stock. Our stockholders have no preemptive or other subscription rights. There are no sinking fund provisions applicable to the common stock, except that we will provide our public stockholders with the opportunity to redeem their public shares for
cash at a per share price equal to the aggregate amount then on deposit in the trust account, including interest earned on the funds held in the trust account (net of permitted withdrawals and up to $100,000 of interest to pay dissolution expenses),
divided by the number of then outstanding public shares, upon the completion of our partnering transaction, subject to the limitations described herein. 

  
 7 

 Founder Shares 

The founder shares are designated as shares of Class F common stock and, except as described below, are identical to the shares of
Class A common stock included in the CAPSTM that were sold in our initial public offering, and holders of founder shares have the same stockholder rights as public stockholders, except
that (i) the founder shares are subject to certain transfer restrictions, as described in more detail below, (ii) our sponsor, officers and directors have entered into a letter agreement with us, pursuant to which they have agreed
(A) to waive their redemption rights with respect to any founder shares, private placement shares and public shares they hold in connection with the completion of our partnering transaction, (B) to waive their redemption rights with
respect to any founder shares, private placement shares and public shares they hold in connection with a stockholder vote to approve an amendment to our amended and restated certificate of incorporation to modify the substance or timing of our
obligation to redeem 100% of our public shares if we have not consummated a partnering transaction within 24 months (or 27 months, as applicable) from the closing of our initial public offering or with respect to any other material provisions
relating to stockholders’ rights or pre-partnering transaction activity and (C) to waive their rights to liquidating distributions from the trust account with respect to any founder shares
or private placement shares they hold if we fail to complete our partnering transaction within 24 months (or 27 months if we have executed a letter of intent, agreement in principle or definitive agreement for our partnering transaction within 24
months) from the closing of our initial public offering, although they will be entitled to liquidating distributions from the trust account with respect to any public shares they hold if we fail to complete our partnering transaction within such
time period, and (iii) the founder shares are automatically convertible into shares of Class A common stock concurrently with or immediately following the consummation of our partnering transaction on a one-for-one basis, subject to adjustment as described herein and in our amended and restated certificate of incorporation. If we submit our partnering transaction to our public stockholders for a
vote, our initial stockholders have agreed to vote their founder shares, performance shares and any public shares purchased during or after our initial public offering in favor of our partnering transaction. 

The founder shares will automatically convert into shares of Class A common stock concurrently with or immediately following the
consummation of our partnering transaction on a one-for-one basis, subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations
and the like, and subject to further adjustment as provided herein. In the case that additional shares of Class A common stock or equity-linked securities are issued or deemed issued in connection with our partnering transaction, the number of
shares of Class A common stock issuable upon conversion of all founder shares will equal, in the aggregate, on an as-converted basis, 5% of the total number of shares of as-converted Class A common stock outstanding after such conversion (including the private placement shares and forward purchase shares but not including any shares of Class A common stock
issuable with respect to performance shares), including the total number of shares of Class A common stock issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by
the Company in connection with or in relation to the consummation of the partnering transaction; provided that such conversion of founder shares into shares of Class A common stock will never occur on a less than one-for-one basis. 
 The founder shares will be entitled to (together with the
performance shares) a number of votes representing 20% of our outstanding common stock (not including the private placement shares) prior to the completion of our partnering transaction. 

  
 8 

 For so long as any founder shares remain outstanding, we may not, without the prior vote or
written consent of the holders of a majority of the founder shares then outstanding, voting separately as a single class, amend, alter or repeal any provision of our certificate of incorporation, whether by merger, consolidation or otherwise, if
such amendment, alteration or repeal would alter or change the powers, preferences or relative, participating, optional or other or special rights of the founder shares. Any action required or permitted to be taken at any meeting of the holders of
the founder shares may be taken without a meeting, without prior notice and without a vote, if a consent or consents in writing, setting forth the action so taken, shall be signed by the holders of the outstanding founder shares having not less than
the minimum number of votes that would be necessary to authorize or take such action at a meeting at which all founder shares were present and voted. 

Performance Shares 
 One of our
fundamental tenets of CAPSTM is alignment of interests. Hence, we believe that it is important to align interests from an economic perspective in our partnering transaction. As part of the
CAPSTM design, we have created an incentive structure which rewards long term performance while also minimizing dilution. We believe that this structure is
more in-line with our long term investment approach and different than existing special purpose acquisition companies. This incentive structure is reflected in the terms of the 120,000 performance
shares issued to the sponsor. 
 On the last day of each fiscal year following the consummation of our partnering transaction (and, with
respect to any year in which we have a change of control or in which we liquidate, dissolve or wind up, on the business day immediately prior to such event instead of on the last day of such fiscal year), 10,000 performance shares will automatically
convert into shares of our Class A common stock (“conversion shares”), as follows: 
  

	 	•	 	 If the price per share of our Class A common stock has not exceeded $27.50 for 20 out of 30 consecutive
trading days at any time following completion of our partnering transaction, the number of conversion shares for any fiscal year will be 1,000 shares of Class A common stock. 

 

	 	•	 	 If the price per share of our Class A common stock exceeded $27.50 for 20 out of any 30 consecutive trading
days at any time following completion of our partnering transaction, then the number of conversion shares for any fiscal year will be the greater of: 

  

	 	•	 	 20% of the increase in the price of one Class A share, year-over-year but in respect of the increase above
the relevant “price threshold” (as defined below), multiplied by the number of shares of Class A common stock outstanding at the close of the partnering transaction, excluding those shares of Class A common stock
received by our sponsor through the Class F common stock, divided by the annual volume weighted average price of shares of our Class A common stock for such fiscal year (the “annual VWAP”) and

  

	 	•	 	 1,000 shares of Class A common stock. 

  
 9 

	 	•	 	 The increase in the price of our shares of Class A common stock will be based on the annual VWAP for the
relevant fiscal year, it being understood that with respect to the 12th fiscal year following our partnering transaction the conversion calculation for the remaining 10,000 performance shares, the calculation described in the immediately preceding
bullet will be based on the greater of (i) the annual VWAP for such fiscal year and (ii) the volume-weighted average price of the shares of our Class A common stock over the last 20 trading days for such fiscal year.

  

	 	•	 	 For purposes of the foregoing calculations, the “price threshold” will initially equal $25.00 for the
first fiscal year following completion of the partnering transaction and will thereafter be adjusted at the beginning of each subsequent fiscal year to be equal to the greater of (i) the annual VWAP for the immediately preceding fiscal year and
(ii) the price threshold for the preceding fiscal year. 

  

	 	•	 	 For calculation purposes, the total number of shares of Class A common stock outstanding at the closing of
the partnering transaction can be no smaller than 27,600,000 shares of Class A common stock and no greater than 55,200,000 shares of Class A common stock. 

 

	 	•	 	 The foregoing calculations will be based on our fiscal year, which may change as a result of our partnering
transaction. 

 For purpose of illustration of the number of shares of Class A common stock that would be issued upon
conversion of the performance shares, assuming the total number of shares of Class A common stock outstanding at the close of the partnering transaction is 24,000,000, assuming the annual VWAP is $20.00 at the end of the first fiscal year
following the completion of the partnering transaction and assuming that the price per share of Class A common stock has not exceeded $27.50 for 20 out of any 30 consecutive trading days following completion of the partnering transaction, then
10,000 performance shares would convert into 1,000 shares of Class A common stock at the end of the first fiscal year. 
 In contrast,
assuming the annual VWAP is $30.00 at the end of the first fiscal year following the completion of the partnering transaction (as opposed to $20.00) and the price per share of Class A common stock has exceeded $27.50 for 20 out of any 30
consecutive trading days after the partnering transaction, the 10,000 performance shares at fiscal year end would convert into 800,000 Class A common stock. The appreciation in the annual VWAP is $30.00 less the initial price threshold of
$25.00, or $5.00. The conversion amount is calculated as 20% of such appreciation, or $1.00, multiplied by 24,000,000, which results in $24,000,000. Such amount is then divided by the annual VWAP of $30.00, which yields 800,000 shares of
Class A common stock. Thus, 10,000 performance share would convert into 800,000 shares of Class A common stock at the end of the first fiscal year. 

Continuing with the example above, at the end of the second fiscal year following the completion of the partnering transaction, assuming the
annual VWAP is $28.00, the 10,000 performance shares at year end would convert into only 1,000 Class A common shares because the annual VWAP for the second fiscal year of $28.00 is less than the annual VWAP of $30.00

  
 10 

 
for the first fiscal year. If the annual VWAP at the end of the second fiscal year following the completion of the partnering transaction was instead $32.00, then the 10,000 performance shares
would convert into 300,000 Class A common stock. The appreciation in the annual VWAP would be $32.00 less $30.00, or $2.00. The conversion amount is calculated as 20% of such appreciation, or $0.40, multiplied by 24,000,000, which results in
$9,600,000. Such amount is then divided by the annual VWAP of $32.00, which yields 300,000 shares of Class A common stock. 
 The
conversion shares shall be deliverable 10 days following the end of each of the first 12 fiscal years following completion of the partnering transaction. 

The price threshold for a particular fiscal year will be reduced by the dividends per share of Class A common stock paid in such fiscal
year. 
 Upon a change of control occurring after our partnering transaction (but not in connection with our partnering transaction),
holders of the performance shares shall receive cash the amount of which is the greater of: (a) the value of approximately approximately 2.8 million shares of Class A common stock or (b) up to $ $69 million. Such calculation
shall decrease by 1/12 each year based on the number of days that have occurred during the fiscal year divided by 360. 
 A change of
control is the occurrence of any one of the following after our partnering transaction (but not in connection with our partnering transaction) if any of the following occurs: (a) a “person” or “group” within the meaning of
Section 13(d) of the Exchange Act, other than us, our wholly owned subsidiaries and our and their respective employee benefit plans, (A) has become the direct or indirect “beneficial owner,” as defined in Rule 13d-3 under the Exchange Act, of common stock representing more than 50% of the voting power of the Common Stock and (B) has filed a Schedule TO or any schedule, form or report under the Exchange
Act disclosing that an event described in clause (A) has occurred; provided, however, that a “person” or “group” shall not be deemed a beneficial owner of, or to own beneficially, any securities tendered pursuant to a tender
or exchange offer made by or on behalf of such “person” or “group” or any of their affiliates until such tendered securities are accepted for purchase or exchange thereunder; (b) the consummation of (A) any
recapitalization, reclassification or change of the common stock (other than a change from no par value to par value, a change in par value or a change from par value to no par value, or changes resulting from a subdivision or combination) as a
result of which all of the common stock would be converted into, or exchanged for, stock, other securities, or other property or assets; (B) any share exchange, consolidation or merger of us pursuant to which all of the Class A common
stock will be converted into cash, securities or other property or assets (including any combination thereof); or (C) any sale, lease or other transfer in one transaction or a series of transactions of all or substantially all of our or our
consolidated assets, taken as a whole, to any person or entity (other than one of our the wholly owned subsidiaries; provided, however, that a transaction described in clauses (A) or (B) in which the holders of all classes of our common
equity immediately prior to such transaction own, directly or indirectly, more than 50% of all classes of the common equity of the continuing or surviving entity immediately after such transaction in substantially the same proportions as such
ownership immediately prior to such transaction shall not be a change of control pursuant to this clause (b); (c) our stockholders approve any plan or proposal for our liquidation or dissolution (other than a liquidation or dissolution that will
occur 

  
 11 

 
contemporaneously with a transaction described in clause (b)(B) above); or (d) our common stock ceases to be listed or quoted on any of The New York Stock Exchange, the NASDAQ Global Select
Market or the NASDAQ Global Market (or any of their respective successors); provided, however, that a transaction or transactions described in clauses (a) or (b) above shall not constitute a change of control, if at least 90% of the
consideration received or to be received by the holders of our common stock, excluding cash payments for fractional shares and cash payments made in respect of dissenters’ appraisal rights, in connection with such transaction or
transactions consists of shares of common stock that are listed or quoted on any of The New York Stock Exchange, the NASDAQ Global Select Market or the NASDAQ Global Market (or any of their respective successors) or will be so listed or quoted when
issued or exchanged in connection with such transaction or transactions, and as a result of such transaction or transactions such consideration becomes the equity interests in which the performance shares convert into. 

For so long as any performance shares remain outstanding, including prior to our partnering transaction, in connection with our partnering
transaction, or following our partnering transaction, we may not, without the prior vote or written consent of the holders of a majority of the performance shares then outstanding, voting separately as a single class, (A) amend, alter or repeal
any provision our amended and restated certificate of incorporation, whether by merger, consolidation or otherwise, if such amendment, alteration or repeal would alter or change the powers, preferences or relative, participating, optional or other
or special rights of the Class B common stock, (B) change our fiscal year, (C) increase the number of directors on the Board, (D) pay any dividends or effect any split on any of our capital stock or make any distributions of
cash, securities or any other property, (E) adopt any stockholder rights plan, (F) acquire any entity or business with assets at a purchase price greater than 10% or more of our total assets measured in accordance with generally accepted
accounting principles in the United States or the accounting standards then used by us in the preparation of our financial statements, (G) issue any Class A shares in excess of 20% of our then outstanding Class A shares or that would
otherwise require a stockholder vote pursuant to the rules of the stock exchange on which the Class A shares are then listed or (H) make a rights offering to all or substantially all of the holders of shares of Class B common stock or
issue additional shares of Class B common stock. Any action required or permitted to be taken at any meeting of the holders of performance shares may be taken without a meeting, without prior notice and without a vote, if a consent or consents
in writing, setting forth the action so taken, shall be signed by the holders of the outstanding Class B common stock having not less than the minimum number of votes that would be necessary to authorize or take such action at a meeting at
which all performance shares were present and voted. 
 The performance shares will be entitled to (together with the founder shares) a
number of votes representing 20% of our outstanding common stock (not including the private placement shares) prior to the completion of our partnering transaction. 

  
 12 

 Sponsor Lockup 

Founder Shares 
 Our sponsor has agreed not
to transfer, assign or sell any of their founder shares until the 180 days following our partnering transaction earlier to occur of: (i) 180 days after the completion of our partnering transaction and (ii) the date on which we complete a
liquidation, merger, capital stock exchange or other similar transaction after our partnering transaction that results in all of our stockholders having the right to exchange their Class A common stock for cash, securities or other property;
except to certain permitted transferees and under certain circumstances as described herein. Any permitted transferees will be subject to the same restrictions and other agreements of our initial stockholders with respect to any founder shares. 

Performance shares and Class A common stock delivered upon conversion thereof 

In addition, our sponsor has agreed not to transfer, assign or sell (i) any of their performance shares except to any permitted
transferees which will be subject to the same restrictions and other agreements of our sponsor with respect to any founder shares, and (ii) any of their Class A common stock deliverable upon conversion of the performance shares for three
years following the completion of our partnering transaction. 
 Preferred Stock 

Our amended and restated certificate of incorporation authorizes 1,000,000 shares of preferred stock and provides that shares of preferred
stock may be issued from time to time in one or more series. Our board of directors is authorized to fix the voting rights, if any, designations, powers, preferences, the relative, participating, optional or other special rights and any
qualifications, limitations and restrictions thereof, applicable to the shares of each series. Our board of directors is able to, without stockholder approval, issue shares of preferred stock with voting and other rights that could adversely affect
the voting power and other rights of the holders of the common stock and could have anti-takeover effects. The ability of our board of directors to issue shares of preferred stock without stockholder approval could have the effect of delaying,
deferring or preventing a change of control of us or the removal of existing management. We have no preferred shares outstanding at the date hereof. Although we do not currently intend to issue any shares of preferred stock, we cannot assure you
that we will not do so in the future. No shares of preferred stock were issued or registered in our initial public offering. 
 Warrants 

Public Stockholders’ Warrants 

Each whole warrant entitles the registered holder to purchase one share of Class A common stock at a price of $28.75 per share, subject to
adjustment as discussed below, at any time commencing on the later of 12 months from the closing of our initial public offering and 30 days after the completion of our partnering transaction, provided in each case that we have an effective
registration statement under the Securities Act of 1933, (the “Securities Act”) covering the shares of Class A common stock issuable upon exercise of the warrants and a current prospectus relating to them is available (or we permit
holders to exercise their warrants on a cashless basis under the circumstances specified in the warrant agreement) and such shares are registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of
residence of the holder. Pursuant to the warrant agreement, a warrant holder may exercise its warrants only for a whole number of shares of Class A common stock. This means only a whole warrant may be exercised at a given time by a warrant
holder. No fractional 

  
 13 

 
warrants will be issued upon separation of the CAPSTM and only whole warrants will trade. Accordingly, unless you purchase at least four
CAPSTM, you will not be able to receive or trade a whole warrant. The warrants will expire five years after the completion of our partnering transaction, at 5:00 p.m., New York City time, or
earlier upon redemption or liquidation. 
 We will not be obligated to deliver any shares of Class A common stock pursuant to the
exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act with respect to the shares of Class A common stock underlying the warrants is then effective and a
prospectus relating thereto is current, subject to our satisfying our obligations described below with respect to registration. No warrant will be exercisable and we will not be obligated to issue a share of Class A common stock upon exercise
of a warrant unless the share of Class A common stock issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants. 

In the event that the conditions in the two immediately preceding sentences are not satisfied with respect to a warrant, the holder of such
warrant will not be entitled to exercise such warrant and such warrant may have no value and expire worthless. In no event will we be required to net cash settle any warrant. In the event that a registration statement is not effective for the
exercised warrants, the purchaser of a CAPSTM containing such warrant will have paid the full purchase price for the CAPSTM solely
for the share of Class A common stock underlying such CAPSTM. 
 We have agreed
that as soon as practicable, but in no event later than fifteen (15) business days after the closing of our partnering transaction, we will use our commercially reasonable efforts to file with the SEC a registration statement for the
registration, under the Securities Act, of the shares of Class A common stock issuable upon exercise of the warrants. We will use our best efforts to cause the same to become effective and to maintain the effectiveness of such registration
statement, and a current prospectus relating thereto, until the expiration of the warrants in accordance with the provisions of the warrant agreement. If a registration statement covering the shares of Class A common stock issuable upon
exercise of the warrants is not effective by the sixtieth (60th) business day after the closing of our partnering transaction, warrant holders may, until such time as there is an effective registration statement and during any period when we will
have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, if our shares of
Class A common stock are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, we may, at
our option, require holders of public warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event we so elect, we will not be required to file or
maintain in effect a registration statement, and in the event we do not so elect, we will use our best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. 

  
 14 

 Redemption of Warrants for Cash 

Once the warrants become exercisable, we may call the warrants for redemption for cash: 

 

	 	•	 	 in whole and not in part; 

 

	 	•	 	 at a price of $0.01 per warrant; 

 

	 	•	 	 upon not less than 30 days’ prior written notice of redemption
(the “30-day redemption period”) to each warrant holder; and 

  

	 	•	 	 if, and only if, the closing price of the common stock equals or exceeds $45.00 per share (as adjusted for stock
splits, stock capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending three business days before we send to the notice of
redemption to the warrant holders. 

 If and when the warrants become redeemable by us for cash, we may exercise our
redemption right even if we are unable to register or qualify the underlying securities for sale under all applicable state securities laws. 

We have established the last of the redemption criterion discussed above to prevent a redemption call unless there is at the time of the call
a significant premium to the warrant exercise price. If the foregoing conditions are satisfied and we issue a notice of redemption of the warrants, each warrant holder will be entitled to exercise his, her or its warrant prior to the scheduled
redemption date. However, the price of the shares of Class A common stock may fall below the $45.00 redemption trigger price (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like) as well as the
$28.75 warrant exercise price after the redemption notice is issued. 
 Redemption Procedures and Cashless Exercise 

If we call the warrants for redemption as described above, our management will have the option to require any holder that wishes to exercise
his, her or its warrant to do so on a “cashless basis.” In determining whether to require all holders to exercise their warrants on a “cashless basis,” our management will consider, among other factors, our cash position, the
number of warrants that are outstanding and the dilutive effect on our stockholders of issuing the maximum number of shares of Class A common stock issuable upon the exercise of our warrants. If our management takes advantage of this option,
all holders of warrants would pay the exercise price by surrendering their warrants for that number of shares of Class A common stock equal to the quotient obtained by dividing (x) the product of the number of shares of Class A common
stock underlying the warrants, multiplied by the excess of the “fair market value” of our shares of Class A common stock (defined below) over the exercise price of the warrants by (y) the fair market value. The “fair market
value” will mean the average closing price of the shares of Class A common stock for the 10 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of warrants. If our
management takes advantage of this option, the notice of redemption will contain the information necessary to calculate the number of shares of Class A common stock to be received upon exercise of the warrants, including the “fair market
value” in such case. Requiring a cashless exercise in this manner will reduce the number of shares to be issued and thereby lessen the dilutive effect of a warrant redemption. We believe this feature is an attractive option to us if we do not
need the cash from the exercise of the warrants after our partnering transaction. If we call our warrants for 

  
 15 

 
redemption and our management does not take advantage of this option, the holders of the private placement CAPSTM and their permitted
transferees would still be entitled to exercise their private placement CAPSTM for cash or on a cashless basis using the same formula described above that other warrant holders would have
been required to use had all warrant holders been required to exercise their warrants on a cashless basis, as described in more detail below. 

A holder of a warrant may notify us in writing in the event it elects to be subject to a requirement that such holder will not have the right
to exercise such warrant, to the extent that after giving effect to such exercise, such person (together with such person’s affiliates), to the warrant agent’s actual knowledge, would beneficially own in excess of 4.9% or 9.8% (as
specified by the holder) of the shares of Class A common stock outstanding immediately after giving effect to such exercise. 
 Adjustment to
Exercise Price 
 If the number of outstanding shares of Class A common stock is increased by a share capitalization payable in
shares of Class A common stock, or by a split-up of common stock or other similar event, then, on the effective date of such share
capitalization, split-up or similar event, the number of shares of Class A common stock issuable on exercise of each warrant will be increased in proportion to such increase in the outstanding
shares of common stock. A rights offering to all or substantially holders of common stock entitling holders to purchase shares of Class A common stock at a price less than the fair market value will be deemed a share capitalization of a number
of shares of Class A common stock equal to the product of (i) the number of shares of Class A common stock actually sold in such rights offering (or issuable under any other equity securities sold in such rights offering that are
convertible into or exercisable for shares of Class A common stock) and (ii) one minus the quotient of (x) the price per share of Class A common stock paid in such rights offering and (y) the fair market value. For
these purposes (i) if the rights offering is for securities convertible into or exercisable for shares of Class A common stock, in determining the price payable for shares of Class A common stock, there will be taken into account any
consideration received for such rights, as well as any additional amount payable upon exercise or conversion and (ii) fair market value means the volume weighted average price of shares of Class A common stock as reported during the ten
(10) trading day period ending on the trading day prior to the first date on which the shares of Class A common stock trades on the applicable exchange or in the applicable market, regular way, without the right to receive such rights.

 In addition, if we, at any time while the warrants are outstanding and unexpired, pay a dividend or make a distribution in cash,
securities or other assets to all or substantially all holders of shares of Class A common stock on account of such shares of Class A common stock (or other securities into which the warrants are convertible), other than (a) as
described above, (b) annual cash dividends in excess of $1.25 per share, (c) to satisfy the redemption rights of the holders of shares of Class A common stock in connection with a proposed partnering transaction or certain amendments
to our certificate of incorporation including an extension of the time period in which we must complete a partnering transaction, or (d) in connection with the redemption of our public shares upon our failure to complete our partnering
transaction, then the warrant exercise price will be decreased, effective immediately after the effective date of such event, by the amount of cash and/or the fair market value of any securities or other assets paid on each share of Class A
common stock in respect of such event. 

  
 16 

 If the number of outstanding shares of Class A common stock is decreased by a
consolidation, combination, reverse share split or reclassification of shares of Class A common stock or other similar event, then, on the effective date of such consolidation, combination, reverse share split, reclassification or similar
event, the number of shares of Class A common stock issuable on exercise of each warrant will be decreased in proportion to such decrease in outstanding share of Class A common stock. 

Whenever the number of shares of Class A common stock purchasable upon the exercise of the warrants is adjusted, as described above, the
warrant exercise price will be adjusted by multiplying the warrant exercise price immediately prior to such adjustment by a fraction (x) the numerator of which will be the number of shares of Class A common stock purchasable upon the
exercise of the warrants immediately prior to such adjustment, and (y) the denominator of which will be the number of shares of Class A common stock so purchasable immediately thereafter. 

In addition, if (x) we issue additional shares of Class A common stock or equity-linked securities, excluding the forward purchase
shares, for capital raising purposes in connection with the closing of our partnering transaction, at an issue price or effective issue price of less than $23.00 per share of Class A common stock (with such issue price or effective issue price
to be determined in good faith by our board of directors and, in the case of any such issuance to our initial stockholders or their affiliates, without taking into account any founder shares held by our initial stockholders or such affiliates, as
applicable, prior to such issuance), (the “Newly Issued Price”) (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of our partnering
transaction on the date of the consummation of our partnering transaction (net of redemptions), and (z) the volume weighted average trading price of our shares of Class A common stock during the 20 trading day period starting on the
trading day after the day on which we consummate our partnering transaction (such price, the “Market Value”) is below $23.00 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 110% of the
higher of the Market Value and the Newly Issued Price, and the $45.00 per share redemption trigger price described below under “Redemption of warrants for cash” will be adjusted (to the nearest cent) to be equal to 180% of the higher of
the Market Value and the Newly Issued Price. 
 In case of any reclassification or reorganization of the outstanding shares of Class A
common stock (other than those described above or that solely affects the par value of such shares of Class A common stock), or in the case of any merger or consolidation of us with or into another corporation (other than a consolidation or
merger in which we are the continuing corporation and that does not result in any reclassification or reorganization of our outstanding shares of Class A common stock), or in the case of any sale or conveyance to another corporation or entity
of the assets or other property of us as an entirety or substantially as an entirety in connection with which we are dissolved, the holders of the warrants will thereafter have the right to purchase and receive, upon the basis and upon the terms and
conditions specified in the warrants and in lieu of the shares of Class A common stock immediately theretofore purchasable and receivable upon the exercise of the rights represented thereby, the kind and amount of shares of Class A common
stock or other securities or property (including cash) receivable upon such 

  
 17 

 
reclassification, reorganization, merger or consolidation, or upon a dissolution following any such sale or transfer, that the holder of the warrants would have received if such holder had
exercised their warrants immediately prior to such event. If less than 70% of the consideration receivable by the holders of shares of Class A common stock in such a transaction is payable in the form of shares of Class A common stock in
the successor entity that is listed for trading on a national securities exchange or is quoted in an established over-the-counter market, or is to be so listed
for trading or quoted immediately following such event, and if the registered holder of the warrant properly exercises the warrant within thirty days following public disclosure of such transaction, the warrant exercise price will be reduced as
specified in the warrant agreement based on the Black-Scholes Warrant Value (as defined in the warrant agreement) of the warrant. The purpose of such exercise price reduction is to provide additional value to holders of the warrants when an
extraordinary transaction occurs during the exercise period of the warrants pursuant to which the holders of the warrants otherwise do not receive the full potential value of the warrants. 

Other Provisions 
 The warrants are issued
in registered form under a warrant agreement between Continental Stock Transfer & Trust Company, as warrant agent, and us. The warrant agreement provides that the terms of the warrants may be amended without the consent of any holder for
the purpose of (i) curing any ambiguity or to correct any defective provision or mistake, including to conform the provisions of the warrant agreement to the description of the terms of the warrants and the warrant agreement set forth in our
initial public offering, (ii) adjusting the provisions relating to cash dividends on shares of common stock as contemplated by and in accordance with the warrant agreement or (iii) adding or changing any provisions with respect to matters
or questions arising under the warrant agreement as the parties to the warrant agreement may deem necessary or desirable and that the parties deem to not adversely affect the rights of the registered holders of the warrants, provided that the
approval by the holders of at least 50% of the then outstanding public warrants that vote to amend the warrant agreement, after at least 10 days’ notice that an amendment is being sought, is required to make any change that adversely affects
the interests of the registered holders of public warrants, and, solely with respect to any amendment to the terms of the private placement warrants, 50% of the then outstanding private placement warrants. 

The warrants may be exercised upon surrender of the warrant certificate on or prior to the expiration date at the offices of the warrant
agent, with the exercise form on the reverse side of the warrant certificate completed and executed as indicated, accompanied by full payment of the exercise price (or on a cashless basis, if applicable), by certified or official bank check payable
to us, for the number of warrants being exercised. The warrant holders do not have the rights or privileges of holders of common stock and any voting rights until they exercise their warrants and receive shares of Class A common stock. After
the issuance of shares of Class A common stock upon exercise of the warrants, each holder will be entitled to one vote for each share held of record on all matters to be voted on by stockholders. 

No fractional shares will be issued upon exercise of the warrants. If, upon exercise of the warrants, a holder would be entitled to receive a
fractional interest in a share, we will, upon exercise, round down to the nearest whole number the number of shares of Class A common stock to be issued to the warrant holder. 

  
 18 

 Voting Limitation 

The warrant agreement provides that no holder may vote more than 15% of the outstanding public warrants (measured on a beneficial basis and
including such holder’s affiliates) unless consented to by us in writing to the warrant agent. In order to vote a warrant, the beneficial owner thereof must identify itself and must represent that it together with its affiliates is not voting
(on a beneficial basis) more than 15% of the outstanding public warrants based on the most recent disclosure by us in a filing with the SEC of the outstanding amounts of public warrants unless we allow a holder to vote greater than 15%. 

Private Placement Warrants 
 The
private placement warrants (including the shares of Class A common stock issuable upon exercise of the private placement CAPSTM) are not transferable, assignable or salable until 30 days
after the completion of our partnering transaction (except, among other limited exceptions) and they will not be redeemable by us for cash so long as they are held by the initial stockholders or their permitted transferees. The initial purchasers,
or their permitted transferees, have the option to exercise the private placement warrants on a cashless basis. Except as described in this section, the private placement warrants have terms and provisions that are identical to those of the warrants
sold as part of the CAPSTM sold in our initial public offering. If the private placement warrants are held by holders other than the initial purchasers or their permitted transferees, the
private placement warrants will be redeemable by us and exercisable by the holders on the same basis as the warrants included in the CAPSTM sold in our initial public offering. 

If holders of the private placement warrants elect to exercise them on a cashless basis, they would pay the exercise price by surrendering
his, her or its warrants for that number of shares of Class A common stock equal to the quotient obtained by dividing (x) the product of the number of shares of Class A common stock underlying the warrants, multiplied by the excess of
the “fair market value” of our shares of Class A common stock (defined below) over the exercise price of the warrants by (y) the fair market value. The “fair market value” will mean the average closing price of the
shares of Class A common stock for the 10 trading days ending on the third trading day prior to the date on which the notice of warrant exercise is sent to the warrant agent. The reason that we have agreed that these warrants will be
exercisable on a cashless basis so long as they are held by the initial purchasers or their permitted transferees is because it is not known at this time whether they will be affiliated with us following a partnering transaction. If they remain
affiliated with us, their ability to sell our securities in the open market will be significantly limited. We have policies in place that prohibit insiders from selling our securities except during specific periods of time. Even during such periods
of time when insiders will be permitted to sell our securities, an insider cannot trade in our securities if he or she is in possession of material non-public information. Accordingly, unlike public
stockholders who could exercise their warrants and sell the shares of Class A common stock received upon such exercise freely in the open market in order to recoup the cost of such exercise, the insiders could be significantly restricted from
selling such securities. As a result, we believe that allowing the holders to exercise such warrants on a cashless basis is appropriate. 

  
 19 

 In order to finance transaction costs in connection with an intended partnering transaction,
our sponsor or an affiliate of our sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. Up to $1,500,000 of such loans may be convertible into private placement CAPSTM of the post partnering transaction entity at a price of $25.00 per private placement CAPSTM at the option of the lender (which CAPSTM will immediately split into Class A shares and warrants). Such warrants would be identical to the private placement warrants. 

Our initial stockholders have agreed not to transfer, assign or sell any of the private placement warrants (including the shares of
Class A common stock issuable upon exercise of any of these warrants) until the date that is 30 days after the date we complete our partnering transaction, except that, among other limited exceptions transfers can be made to our officers and
directors and other persons or entities affiliated with the sponsor. 
 Dividends 

We have not paid any cash dividends on our common stock to date and do not intend to pay cash dividends prior to the completion of a partnering
transaction. The payment of cash dividends in the future will be dependent upon our revenues and earnings, if any, capital requirements and general financial condition subsequent to completion of a partnering transaction. The payment of any cash
dividends subsequent to a partnering transaction will be within the discretion of our board of directors at such time. Further, if we incur any indebtedness, our ability to declare dividends may be limited by restrictive covenants we may agree to in
connection therewith. 
 Our Transfer Agent and Warrant Agent 

The transfer agent for our common stock and warrant agent for our warrants is Continental Stock Transfer & Trust Company. We have
agreed to indemnify Continental Stock Transfer & Trust Company in its roles as transfer agent and warrant agent, its agents and each of its stockholders, directors, officers and employees against all claims and losses that may arise out of
acts performed or omitted for its activities in that capacity, except for any liability due to any gross negligence or intentional misconduct of the indemnified person or entity. Continental Stock Transfer & Trust Company has agreed that it
has no right of set-off or any right, title, interest or claim of any kind to, or to any monies in, the trust account, and has irrevocably waived any right, title, interest or claim of any kind to,
or to any monies in, the trust account that it may have now or in the future. Accordingly, any indemnification provided will only be able to be satisfied, or a claim will only be able to be pursued, solely against us and our assets outside the trust
account and not against the any monies in the trust account or interest earned thereon. 
 Amended and Restated Certificate of Incorporation 

Our amended and restated certificate of incorporation contains certain requirements and restrictions that apply to us until the completion of
our partnering transaction. These provisions cannot be amended without the approval of the holders of 60% of the voting power of our common stock. Our initial stockholders, who will collectively beneficially own 5% of our Class A common stock
issued in our initial public offering (assuming they do not purchase any CAPSTM in our initial public offering), may participate in any vote to amend our amended and restated certificate of
incorporation and will have the discretion to vote in any manner they 

  
 20 

 
choose. Specifically, our amended and restated certificate of incorporation provides, among other things, that: 
  

	 	•	 	 If we do not complete our partnering transaction within 24 months (or 27 months, as applicable) from the closing
of our initial public offering, we will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest earned on the funds held in the trust account (net of permitted withdrawals and up
to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further
liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining stockholders and our board of directors, liquidate and dissolve, subject in each case to our
obligations under Delaware law to provide for claims of creditors and in all cases subject to the requirements of other applicable law; 

  

	 	•	 	 Prior to our partnering transaction, we may not issue additional securities that would entitle the holders
thereof to (i) receive funds from the trust account or (ii) vote as a class with our public shares (a) on our partnering transaction or (b) to approve an amendment to our amended and restated certificate of incorporation to
(x) extend the time we have to consummate a partnering transaction beyond 24 months (or 27 months, as applicable) from the closing of our initial public offering or (y) amend the foregoing provisions; 

 

	 	•	 	 Although we do not intend to enter into a partnering transaction with a partnering candidate that is affiliated
with our sponsor, our directors or our executive officers, we are not prohibited from doing so. In the event we enter into such a transaction, we, or a committee of independent directors, will obtain an opinion from an independent investment banking
firm or an independent accounting firm that such a partnering transaction is fair to our company from a financial point of view; 

  

	 	•	 	 If a stockholder vote on our partnering transaction is not required by law and we do not decide to hold a
stockholder vote for business or other legal reasons, we will offer to redeem our public shares pursuant to Rule 13e-4 and Regulation 14E of the Exchange Act, and will file tender offer documents
with the SEC prior to completing our partnering transaction which contain substantially the same financial and other information about our partnering transaction and the redemption rights as is required under Regulation 14A of the Exchange Act.
Whether or not we maintain our registration under the Exchange Act or our listing on the NYSE, we will provide our public stockholders with the opportunity to redeem their public shares by one of the two methods listed above; 

  
 21 

	 	•	 	 So long as we obtain and maintain a listing for our securities on the NYSE, the NYSE rules require that we must
complete one or more partnering transactions having an aggregate fair market value of at least 80% of the value of the assets held in the trust account (excluding the taxes payable on the interest earned on the trust account) at the time of the
agreement to enter into the partnering transaction; 

  

	 	•	 	 If our stockholders approve an amendment to our amended and restated certificate of incorporation to modify the
substance or timing of our obligation to redeem 100% of our public shares if we do not complete our partnering transaction within 24 months (or 27 months, as applicable) from the closing of our initial public offering, or with respect to any other
material provisions relating to stockholders’ rights or pre-partnering transaction activity, we will provide our public stockholders with the opportunity to redeem all or a portion of their
shares of Class A common stock upon such approval at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest earned on the
funds held in the trust account (net of permitted withdrawals and up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, subject to the limitations described herein; and

  

	 	•	 	 We will not effectuate our partnering transaction solely with another blank check company or a similar company
with nominal operations. 

 In addition, our amended and restated certificate of incorporation provides that under no
circumstances will we redeem our public shares in an amount that would cause our net tangible assets to be less than $5,000,001. 
 Certain Anti-Takeover
Provisions of Delaware Law and our Amended and Restated Certificate of Incorporation and Bylaws 
 We have opted out of Section 203
of the DGCL. However, our amended and restated certificate of incorporation contains similar provisions providing that we may not engage in certain “partnering transactions” with any “interested stockholder” for a three-year
period following the time that the stockholder became an interested stockholder, unless: 
  

	 	•	 	 prior to such time, our board of directors approved either the partnering transaction or the transaction which
resulted in the stockholder becoming an interested stockholder; 

  

	 	•	 	 upon consummation of the transaction that resulted in the stockholder becoming an interested stockholder, the
interested stockholder owned at least 85% of our voting stock outstanding at the time the transaction commenced, excluding certain shares; or 

  

	 	•	 	 at or subsequent to that time, the partnering transaction is approved by our board of directors and by the
affirmative vote of holders of at least 66-2/3% of the outstanding voting stock that is not owned by the interested stockholder. 

Generally, a “partnering transaction” includes a merger, asset or stock sale or certain other transactions resulting in a financial
benefit to the interested stockholder. Subject to certain exceptions, an “interested stockholder” is a person who, together with that person’s affiliates and associates, owns, or within the previous three years owned, 15% or more of
our voting stock. 

  
 22 

 Under certain circumstances, this provision will make it more difficult for a person who
would be an “interested stockholder” to effect various partnering transactions with a corporation for a three-year period. This provision may encourage companies interested in acquiring our company to negotiate in advance with our board of
directors because the stockholder approval requirement would be avoided if our board of directors approves either the partnering transaction or the transaction which results in the stockholder becoming an interested stockholder. These provisions
also may have the effect of preventing changes in our board of directors and may make it more difficult to accomplish transactions which stockholders may otherwise deem to be in their best interests. 

Our amended and restated certificate of incorporation provides that Periphas Capital, the Sponsor and their respective affiliates, any of
their respective direct or indirect transferees of at least 15% of our outstanding common stock and any group as to which such persons are party to, do not constitute “interested stockholders” for purposes of this provision. 

Our amended and restated certificate of incorporation provides that our board of directors is classified into three classes of directors. As a
result, in most circumstances, a person can gain control of our board only by successfully engaging in a proxy contest at two or more annual meetings. 

Our authorized but unissued common stock and preferred stock are available for future issuances without stockholder approval (including a
specified future issuance) and could be utilized for a variety of corporate purposes, including future offerings to raise additional capital, acquisitions and employee benefit plans. The existence of authorized but unissued and unreserved common
stock and preferred stock could render more difficult or discourage an attempt to obtain control of us by means of a proxy contest, tender offer, merger or otherwise. 

Exclusive Forum for Certain Lawsuits 
 Our
amended and restated certificate of incorporation requires, unless we consent in writing to the selection of an alternative forum, that (i) any derivative action or proceeding brought on our behalf, (ii) any action asserting a claim of
breach of a fiduciary duty owed by any director, officer or other employee to us or our stockholders, (iii) any action asserting a claim against us, our directors, officers or employees arising pursuant to any provision of the DGCL or our
amended and restated certificate of incorporation or bylaws, or (iv) any action asserting a claim against us, our directors, officers or employees governed by the internal affairs doctrine may be brought only in the Court of Chancery in the
State of Delaware, except any claim (A) as to which the Court of Chancery of the State of Delaware determines that there is an indispensable party not subject to the jurisdiction of the Court of Chancery (and the indispensable party does not
consent to the personal jurisdiction of the Court of Chancery within ten days following such determination), (B) which is vested in the exclusive jurisdiction of a court or forum other than the Court of Chancery, (C) for which the Court of
Chancery does not have subject matter jurisdiction, or (D) any action arising under the Securities Act, as to which the U.S. federal district courts shall have exclusive jurisdiction, unless we consent otherwise. If an action is brought outside
of Delaware, the stockholder bringing the suit will be deemed to have consented to service of process on such stockholder’s counsel. Although we believe this provision benefits us by providing increased consistency in the application of
Delaware law in 

  
 23 

 
the types of lawsuits to which it applies, a court may determine that this provision is unenforceable, and to the extent it is enforceable, the provision may have the effect of discouraging
lawsuits against our directors and officers, although our stockholders will not be deemed to have waived our compliance with federal securities laws and the rules and regulations thereunder. 

Notwithstanding the foregoing, our amended and restated certificate of incorporation provides that the exclusive forum provision will not
apply to suits brought to enforce a duty or liability created by the Exchange Act or any other claim for which the federal courts have exclusive jurisdiction. Section 27 of the Exchange Act creates exclusive federal jurisdiction over all suits
brought to enforce any duty or liability created by the Exchange Act or the rules and regulations thereunder. Although we believe this provision benefits us by providing increased consistency in the application of Delaware law in the types of
lawsuits to which it applies, the provision may have the effect of discouraging lawsuits against our directors and officers. Unless we consent in writing to the selection of an alternative forum, the federal district courts of the United States of
America will be the exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act. 
 Special Meeting
of Stockholders 
 Our bylaws provide that special meetings of our stockholders may be called only by a majority vote of our board of
directors, by our Chief Executive Officer or by our Chairman. 
 Advance Notice Requirements for Stockholder Proposals and Director Nominations 

Our bylaws provide that stockholders seeking to bring business before our annual meeting of stockholders, or to nominate candidates for
election as directors at our annual meeting of stockholders, must provide timely notice of their intent in writing. To be timely, a stockholder’s notice will need to be received by the company secretary at our principal executive offices not
later than the close of business on the 90th day nor earlier than the opening of business on the 120th day prior to the anniversary date of the immediately preceding annual meeting of stockholders. Pursuant to
Rule 14a-8 of the Exchange Act, proposals seeking inclusion in our annual proxy statement must comply with the notice periods contained therein. Our bylaws also specify certain requirements as to the
form and content of a stockholders’ meeting. These provisions may preclude our stockholders from bringing matters before our annual meeting of stockholders or from making nominations for directors at our annual meeting of stockholders. 

Action by Written Consent 
 Following to
the consummation of our initial public offering, any action required or permitted to be taken by our common stockholders must be effected by a duly called annual or special meeting of such stockholders and may not be effected by written consent of
the stockholders other than with respect to our founder shares and our performance shares. 

  
 24 

 Classified Board of Directors 

Our board of directors is divided into three classes, Class I, Class II and Class III, with members of each class serving
staggered three-year terms. Our amended and restated certificate of incorporation provides that the authorized number of directors may be changed only by resolution of the board of directors. Subject to the terms of any preferred stock, any or all
of the directors may be removed from office at any time, but only for cause and only by the affirmative vote of holders of a majority of the voting power of all then outstanding shares of our capital stock entitled to vote generally in the election
of directors, voting together as a single class. Any vacancy on our board of directors, including a vacancy resulting from an enlargement of our board of directors, may be filled only by vote of a majority of our directors then in office. 

Securities Eligible for Future Sale 
 We
have 17,753,600 shares of Class A common stock issued and outstanding on an as-converted basis. Of these shares, the shares of Class A common stock sold in our initial public offering
16,560,000 shares of Class A common stock will be freely tradable without restriction or further registration under the Securities Act, except for any shares of Class A common stock purchased by one of our affiliates within the meaning of
Rule 144 under the Securities Act. All of the 828,000 outstanding founder shares, all of the 245,600 outstanding private placement CAPSTM, all of the 120,000 outstanding performance shares, and
the securities underlying the foregoing, will be restricted securities under Rule 144, in that they were issued in private transactions not involving a public offering. Upon the closing of the sale of the forward purchase shares, the forward
purchase shares that are purchased will be restricted securities under Rule 144. 
 Rule 144 

Pursuant to Rule 144, a person who has beneficially owned restricted shares or warrants for at least six months would be entitled to sell their
securities provided that (i) such person is not deemed to have been one of our affiliates at the time of, or at any time during the three months preceding, a sale and (ii) we are subject to the Exchange Act periodic reporting requirements
for at least three months before the sale and have filed all required reports under Section 13 or 15(d) of the Exchange Act during the 12 months (or such shorter period as we were required to file reports) preceding the sale. 

Persons who have beneficially owned restricted shares or warrants for at least six months but who are our affiliates at the time of, or at any
time during the three months preceding, a sale, would be subject to additional restrictions, by which such person would be entitled to sell within any three-month period only a number of securities that does not exceed the greater of: 

 

	 	•	 	 1% of the total number of shares of common stock then outstanding, which equals 177,536 shares; or

  

	 	•	 	 the average weekly reported trading volume of the shares of Class A common stock during the four calendar
weeks preceding the filing of a notice on Form 144 with respect to the sale. 

 Sales by our affiliates under Rule 144 are
also limited by manner of sale provisions and notice requirements and to the availability of current public information about us. 

  
 25 

 Rule 144 is not available for the resale of securities initially issued by shell companies
(other than business combination related shell companies) or issuers that have been at any time previously a shell company. However, Rule 144 also includes an important exception to this prohibition if the following conditions are met: 

 

	 	•	 	 the issuer of the securities that was formerly a shell company has ceased to be a shell company;

  

	 	•	 	 the issuer of the securities is subject to the reporting requirements of Section 13 or 15(d) of the Exchange
Act; 

  

	 	•	 	 the issuer of the securities has filed all Exchange Act reports and material required to be filed, as applicable,
during the preceding 12 months (or such shorter period that the issuer was required to file such reports and materials), other than Form 8-K reports; and 

 

	 	•	 	 at least one year has elapsed from the time that the issuer filed current Form 10 type information with the SEC
reflecting its status as an entity that is not a shell company. 

 As a result, our initial shareholders will be able to
sell their founder shares and our sponsor will be able to sell its private placement CAPSTM, and the securities underlying the foregoing, pursuant to Rule 144 without registration one year after
we have completed our initial partnering transaction. 
 Registration and Stockholder Rights 

The holders of the founder shares, performance shares, forward purchase shares, private placement shares or private placement warrants
underlying private placement CAPSTM, and private placement CAPSTM that may be issued upon conversion of working capital loans (and any
shares of Class A common stock issuable upon the exercise of the private placement warrants that are part of the private placement CAPSTM, and CAPSTM may be issued upon conversion of working capital loans and upon conversion of the founder shares and the performance shares) are entitled to registration rights pursuant to a registration and
stockholder rights agreement that the holders signed at the closing of our initial public offering, requiring us to register such securities for resale. The holders of these securities are entitled to make up to three demands, excluding short form
demands, that we register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to our completion of our partnering transaction. We will bear the
expenses incurred in connection with the filing of any such registration statements. Pursuant to the registration and stockholder rights agreement, our sponsor, upon and following consummation of an initial partnering transaction, will be entitled
to nominate three individuals for election to our board of directors, as long as the sponsor holds any securities covered by the registration and stockholder rights agreement. 

Listing of Securities 
 Our CAPSTM are listed on the NYSE under the symbol “PCPC.U” The shares of Class A common stock and warrants are listed on the NYSE under the symbols “PCPC” and “PCPC WS,”
respectively. 

  
 26SECURITIES
PURCHASE AGREEMENT

 

This Securities
Purchase Agreement (this “Agreement”) is dated as of February 3, 2016, by and among GrandSouth Bancorporation,
a South Carolina corporation (the “Company”), and each purchaser identified on the signature pages hereto (each,
including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).

 

RECITALS

 

A.                      
The Company and each Purchaser are executing and delivering this Agreement in reliance
upon the exemption from securities registration afforded by Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities
Act”), and Rule 506 of Regulation D (“Regulation D”) as promulgated by the United States Securities
and Exchange Commission (the “Commission”) under the Securities Act.

B.                      
Each Purchaser, severally and not jointly, wishes to purchase, and the Company
wishes to sell, upon the terms and conditions stated in this Agreement, that aggregate number of shares of common stock, no par
value per share, of the Company (the “Common Stock”) set forth below such Purchaser’s name on the signature
page of this Agreement (which aggregate amount for all Purchasers together shall be 666,668 shares of Common Stock and shall be
collectively referred to herein as the “Shares”).

C.                      
In addition to the sale of Shares to the Purchasers contemplated by this Agreement,
the Company intends to effect one or more private placement transactions of additional shares of Common Stock with other accredited
investors (the “Additional Investors”), with the closing of such sale to occur simultaneously with the Closing
(the “Other Private Placements”). The aggregate number of shares of Common Stock subscribed for by the Purchasers
and the Additional Investors collectively shall be 1,000,000 shares of Common Stock and each share of Common Stock shall be sold
at a price of$12.00 per share. In connection with the Other Private Placements, the Company shall enter into agreements with the
Additional Investors (the “Additional Agreements”).

 

C.       The
Company has engaged FIG Partners LLC as its exclusive placement agent (the “Placement Agent”) for the offering
of the Shares.

NOW, THEREFORE,
IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt
and adequacy of which are hereby acknowledged, the Company and the Purchasers hereby agree as follows:

 

ARTICLE
I 

DEFINITIONS

 

1.1       Definitions.
In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms shall
have the meanings indicated in this Section 1.1:

 

    	 	  	 

     

    

“Action”
means arty Proceeding, inquiry, or notice of violation pending or, to the Company’s Knowledge, threatened in writing
against the Company, any Subsidiary or any of their respective properties or any officer, director or employee of the Company
or any Subsidiary acting in his or her capacity as an officer, director or employee before or by any federal, state, county, local
or foreign court, arbitrator, governmental or administrative agency, regulatory authority, stock market, stock exchange or trading
facility.

 

“Affiliate”
means, with respect to any Person, any other Person that, directly or indirectly through one or more intermediaries, Controls,
is controlled by or is under common control with such Person, as such terms are used in and construed under Rule 405 under the
Securities Act.

 

“Agency”
has the meaning set forth in Section 3.1(qq).

 

“Agreement”
shall have the meaning ascribed to such term in the Preamble.

 

“Articles
of Incorporation” means the Articles of Incorporation of the Company and all amendments and certificates of determination
thereto, as the same may be amended from time to time.

 

“Bank”
means GrandSouth Bank, a South Carolina banking corporation and wholly- owned Subsidiary of the Company.

 

“Bank
Regulatory Authorities” has the meaning set forth in Section 3.1(b)(ii).

 

“BHC
Act” has the meaning set forth in Section 3.1(b)(ii).

 

“Board”
has the meaning set forth in Section 2.2(a)(iv).

 

“Board
of Financial Institutions” has the meaning set forth in Section 3.1(b)(ii).

 

“Business
Day” means a day, other than a Saturday or Sunday, on which banks in the City of New York are open for the general transaction
of business.

 

“Buy-In”
has the meaning set forth in Section 4.1(e).

 

“Buy-In
Price” has the meaning set forth in Section 4.1(e).

 

“CIBC
Act” means the Change in Bank Control Act.

 

“Closing”
means the closing of the purchase and sale of the Shares pursuant to this Agreement.

 

    	 	 2	 

     

    

“Closing
Bid Price” means, for any security as of any date, the last closing price for such security on the Principal Trading
Market, as reported by Bloomberg, or, if the Principal Trading Market begins to operate on an extended hours basis and does not
designate the closing bid price then the last bid price of such security prior to 4:00 p.m., New York City Time, as reported by
Bloomberg, or, if the Principal Trading Market is not the principal securities exchange or trading market for such security, the
last closing price of such security on the principal securities exchange or trading market where such security is listed or traded
as reported by Bloomberg, or if the foregoing do not apply, the last closing price of such security in the over-the-counter market
on the electronic bulletin board for such security as reported by Bloomberg, or, if no closing bid price is reported for such
security by Bloomberg, the average of the bid prices of any market makers for such security as reported in the “pink sheets”
by OTC Markets Group Inc. If the Closing Bid Price cannot be calculated for a security on a particular date on any of the foregoing
bases, the Closing Bid Price of such security on such date shall be the fair market value as mutually determined by the Company
and the holder. If the Company and the holder are unable to agree upon the fair market value of such security, then the Company
shall, within two Business Days submit via facsimile (a) the disputed determination to an independent, reputable investment bank
selected by the Company and approved by the holder or (b) the disputed arithmetic calculation to the Company’s independent,
outside accountant. The Company shall cause at its expense the investment bank or the accountant, as the case may be, to perform
the determinations or calculations and notify the Company and the holder of the results no later than ten Business Days from the
time it receives the disputed determinations or calculations. Such investment bank’s or accountant’s determination
or calculation, as the case may be, shall be binding upon all parties absent demonstrable error. All such determinations shall
be appropriately adjusted for any stock dividend, stock split, stock combination or other similar transaction during the applicable
calculation period.

 

“Closing
Date” means the Trading Day when all of the Transaction Documents have been executed and delivered by the applicable
parties thereto, and all of the conditions set forth in Sections 2.1, 2.2, 5.1 and 5.2 hereof are satisfied or waived, as the
case may be, or such other date as the parties may agree.

 

“Commission”
has the meaning set forth in the Recitals.

 

“Common
Stock” has the meaning set forth in the Recitals, and also includes any securities into which the Common Stock may hereafter
be reclassified or changed.

 

“Company
Counsel” means Haynsworth Sinkler Boyd, P.A.

 

“Company
Deliverables” has the meaning set forth in Section 2.2(a).

 

“Company
Reports” has the meaning set forth in Section 3.1(mm).

 

“Company’s
Knowledge” means, with respect to any statement made to the knowledge of the Company, that the statement is based upon
the actual knowledge of the executive officers of the Company having responsibility for the matter or matters that are the subject
of the statement after reasonable investigation.

 

“Control”
(including the terms “controlling”, “controlled by” or “under common control with”) means
the possession, direct or indirect, of the power to direct or cause the direction of the management and policies of a Person,
whether through the ownership of voting securities, by contract or otherwise.

 

“Covered
Securities” has the meaning set forth in Section 4.14(a).

 

    	 	 3	 

     

    

“Designated
Securities” has the meaning set forth in Section 4.14(b).

 

“DTC”
means The Depository Trust Company.

 

“Environmental
Laws” has the meaning set forth in Section 3.1(l).

 

“ERISA”
has the meaning set forth in Section 3.1(ss).

 

“Exchange
Act” means the Securities Exchange Act of 1934, as amended, or any successor statute, and the rules and regulations
promulgated thereunder.

 

“FDIC”
has the meaning set forth in Section 3.1(b)(ii).

 

“Federal
Reserve” has the meaning set forth in Section 3.1(b)(ii)

 

“GAAP”
means U.S. generally accepted accounting principles, as applied by the Company.

 

“Indemnified
Person” has the meaning set forth in Section 4.8(a).

 

“Insurer”
has the meaning set forth in Section 3.1(qq).

 

“Intellectual
Property” has the meaning set forth in Section 3.1(r).

 

“Lien”
means any lien, charge, claim, encumbrance, security interest, right of first refusal, preemptive right or other restriction
of any kind.

 

“Loan
Investor” has the meaning set forth in Section 3.1(qq).

 

“Material
Adverse Effect” means any of (i) a material and adverse effect on the legality, validity or enforceability of any Transaction
Document, (ii) a material and adverse effect on the results of operations, assets, properties, business, condition (financial
or otherwise) or prospects of the Company and the Subsidiaries, taken as a whole, or (iii) any adverse impairment to the Company’s
ability to perform in any material respect on a timely basis its obligations under any Transaction Document.

 

“Material
Contract” means any contract of the Company that is material to the financial condition or operations of the Company.

 

“Material
Permits” has the meaning set forth in Section 3.1(p).

 

“Money
Laundering Laws” has the meaning set forth in Section 3.1(jj).

 

“New
York Courts” means the courts of the State of New York and the United States District Courts located in the city of
New York.

 

“OFAC”
has the meaning set forth in Section 3.1(ii).

 

    	 	 4	 

     

    

“Offer
Period” has the meaning set forth in Section 4.14(b).

 

“Outside
Date” means the fifteenth (15th) day following the date of this Agreement; provided that if such day is not
a Business Day, the first day following such day that is a Business Day.

 

“Person”
means an individual, corporation, partnership, limited liability company, trust, business trust, association, joint stock
company, joint venture, sole proprietorship, unincorporated organization, governmental authority or any other form of entity not
specifically listed herein.

 

“Placement
Agent” has the meaning set forth in the Recitals.

 

“Principal
Trading Market” means the Trading Market on which the Common Stock is primarily listed on and quoted for trading, which,
as of the date of this Agreement and the Closing Date, is the OTC Bulletin Board.

 

“Proceeding”
means an action, claim, suit, investigation or proceeding (including, without limitation, an investigation or partial proceeding,
such as a deposition), whether commenced or threatened.

 

“Purchase
Price” means $12.00 per Share.

 

“Purchaser
Deliverables” has the meaning set forth in Section 2.2(b).

 

“Qualified
Offering” has the meaning set forth in Section 4.14(a).

 

“Qualified
Offering Notice” has the meaning set forth in Section 4.14(b).

 

“Qualified
Purchaser” has the meaning set forth in Section 4.14(a).

 

“Qualified
Purchaser Percentage Interest” has the meaning set forth in Section 4.14(a).

 

“Regulation
D” has the meaning set forth in the Recitals.

 

“Regulatory
Agreement” has the meaning set forth in Section 3.1(oo).

 

“Required
Approvals” has the meaning set forth in Section 3.1(e).

 

“Rule
144” means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time
to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule.

 

“Rule
144A Offering” has the meaning set forth in Section 4.14(c).

 

“Securities
Act” means the Securities Act of 1933, as amended.

 

    	 	 5	 

     

    

“Subscription
Amount” means with respect to each Purchaser, the aggregate amount to be paid for the Shares purchased hereunder as
indicated on such Purchaser’s signature page to this Agreement next to the heading “Aggregate Purchase Price (Subscription
Amount)”.

 

“Subsidiary”
means the Bank and any other entity in which the Company, directly or indirectly, owns sufficient capital stock or holds a
sufficient equity or similar interest such that it is consolidated with the Company in the financial statements of the Company.

 

“Trading
Day” means (i) a day on which the Common Stock is listed or quoted and traded on its Principal Trading Market (other
than the OTC Bulletin Board), or (ii) if the Common Stock is not listed on a Trading Market (other than the OTC Bulletin Board),
a day on which the Common Stock is traded in the over-the-counter market, as reported by the OTC Bulletin Board, or (iii) if the
Common Stock is not quoted on any Trading Market, a day on which the Common Stock is quoted in the over-the-counter market as
reported in the “pink sheets” by OTC Markets Group Inc. (or any similar organization or agency succeeding to its functions
of reporting prices); provided, that in the event that the Common Stock is not listed or quoted as set forth in (i), (ii) and
(iii) hereof, then Trading Day shall mean a Business Day.

 

“Trading
Market” means whichever of the New York Stock Exchange, the NYSE MKT, the NASDAQ Global Select Market, the NASDAQ Global
Market, the NASDAQ Capital Market or the OTC Bulletin Board on which the Common Stock is listed or quoted for trading on the date
in question.

 

“Transaction
Documents” means this Agreement, the schedules and exhibits attached hereto and any other documents or agreements executed
or delivered in connection with the transactions contemplated hereunder.

 

“Transfer
Agent” means Computershare, Inc., or any successor transfer agent for the Company.

 

ARTICLE
II 

PURCHASE AND SALE

 

		2.1	Closing.

 

(a)                   
Purchase of Shares. Subject to the terms and conditions set forth in this Agreement,
at the Closing the Company shall issue and sell to each Purchaser, and each Purchaser shall, severally and not jointly, purchase
from the Company, the number of Shares set forth below such Purchaser’s name on the signature page of this Agreement at
a per Share price equal to the Purchase Price.

 

(b)                  
Closing. The Closing of the purchase and sale of the Shares shall take place
on the Closing Date remotely by facsimile transmission or other electronic means as the parties may mutually agree.

 

(c)                   
Form of Payment. Unless otherwise agreed to by the Company and a Purchaser
(as to itself only), on the Closing Date, (1) the Company shall deliver to each Purchaser one or more stock certificates, evidencing
the number of Shares set forth on such Purchaser’s signature page to this Agreement and (2) upon receipt thereof, each Purchaser
shall wire its Subscription Amount, in United States dollars and in immediately available funds, in accordance with the Company’s
written wire transfer instructions. For purposes of clarity, a Purchaser shall not be required to wire its Subscription Amount
until it (or its designated custodian per its delivery instructions) confirms receipt of its Shares.

 

    	 	 6	 

     

    
		2.2	Closing
                                         Deliveries.

                                         

                                         

(a)                  
On or prior to the Closing, the Company shall issue, deliver or cause to be delivered
to each Purchaser the following (the “Company Deliverables”):

(i)                    
this Agreement, duly executed by the Company;

 

(ii)                  
one or more stock certificates, evidencing the Shares subscribed for by Purchaser
hereunder, registered in the name of such Purchaser or its nominee (per its instructions) (the “Stock Certificates”);

(iii)                
a legal opinion of Company Counsel, dated as of the Closing Date and in the form attached
hereto as Exhibit B, executed by such counsel and addressed to the Purchasers;

 

(iv)                
a certificate of the Secretary of the Company, in the form attached hereto as Exhibit
C, dated as of the Closing Date, (a) certifying the resolutions adopted by the Board of Directors of the Company (the “Board”)
or a duly authorized committee thereof approving the transactions contemplated by this Agreement and the other Transaction
Documents, including the issuance of the Shares, (b) certifying the current versions of the articles of incorporation, as amended,
and bylaws, as amended, of the Company and (c) certifying as to the signatures and authority of persons signing the Transaction
Documents and related documents on behalf of the Company;

(v)                  
a certificate of the Chief Executive Officer or Chief Financial Officer of the Company,
in the form attached hereto as Exhibit D, dated as of the Closing Date, certifying to the fulfillment of the conditions
specified in Sections 5.I(a) and 5.l(b); and

 

(vi)                 
a Certificate of Good Standing for the Company from the South Carolina Secretary of
State as of a recent date.

(b)                  
On or prior to the Closing, each Purchaser shall deliver or cause to be delivered
to the Company the following (the “Purchaser Deliverables”):

		(i)	this
                                         Agreement, duly executed by such Purchaser;

 

(ii)            
its Subscription Amount, in U.S. dollars and in immediately available funds, by wire
transfer in accordance with the Company’s written instructions; and

    	 	 7	 

     

    

(iii)          
a fully completed and duly executed Accredited Investor Questionnaire in the form
attached hereto as Exhibit A.

 

ARTICLE III

REPRESENTATIONS AND WARRANTIES

 

3.1                   
Representations and Warranties of the Company. The Company hereby represents and warrants as of the date hereof
and as of the Closing Date (except for the representations and warranties that speak as of a specific date, which shall be made
as of such date), to each of the Purchasers that:

 

(a)           Subsidiaries. The Company has no direct or indirect Subsidiaries other than
the Bank. The Company owns, directly or indirectly, all of the capital stock or comparable equity interests of the Bank free and
clear of any and all Liens, and all the issued and outstanding shares of capital stock or comparable equity interest of the Bank
are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities.

 

		(b)	Organization
                                         and Qualification; Bank Regulations.

 

(i)                 
Each of the Company and the Bank is an entity duly incorporated or otherwise organized,
validly existing and in good standing under the laws of the jurisdiction of its incorporation or organization (as applicable),
with the requisite power and authority to own or lease and use its properties and assets and to carry on its business as currently
conducted. Neither the Company nor the Bank is in violation of any of the provisions of its respective certificate or articles
of incorporation, bylaws or other organizational or charter documents. Each of the Company and the Bank is duly qualified to conduct
business and is in good standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business
conducted or property owned by it makes such qualification necessary, except where the failure to be so qualified or in good standing,
as the case may be, would not be expected to have a Material Adverse Effect.

(ii)               
The Company is duly registered as a bank holding company under the Bank Holding Company
Act of 1956, as amended (the “BHC Act”). The Bank is the Company’s only subsidiary banking subsidiary.
The Bank holds the requisite authority from the South Carolina State Board of Financial Institutions (the “Board of Financial
Institutions”) to do business as a state-chartered banking corporation under the laws of the State of South Carolina.
Each of the Company and the Bank is in compliance with all laws administered by the Board of Governors of the Federal Reserve
System (the “Federal Reserve”), the Federal Deposit Insurance Corporation (the “FDIC”), the
Board of Financial Institutions and any other federal or state bank regulatory authorities (together with the Board of Financial
Institutions, the Federal Reserve and the FDIC, the “Bank Regulatory Authorities”) with jurisdiction over the
Company and its Subsidiaries, except for any noncompliance that, individually or in the aggregate, has not had and would not be
reasonably expected to have a Material Adverse Effect. The deposit accounts of the Hank are insured up to applicable limits by
the FDIC, and all premiums and assessments required to be paid in connection therewith have been paid when due.

    	 	 8	 

     

    

(c)                     
Authorization: Enforcement; Validity. The Company has the requisite corporate
power and authority to enter into and to consummate the transactions contemplated hereby and by each of the other Transaction
Documents to which it is a party and the Additional Agreements and otherwise to carry out its obligations hereunder and thereunder,
including, without limitation, to issue the Shares in accordance with the terms hereof and the shares of Common Stock in accordance
with the Additional Agreements. The Company’s execution and delivery of each of the Transaction Documents and the Additional
Agreements and the consummation by it of the transactions contemplated hereby and thereby (including, but not limited to, the
sale and delivery of the Shares hereunder and the shares of Common Stock in accordance with the Additional Agreements) have been
duly authorized by all necessary corporate action on the part of the Company, and no further corporate action is required by the
Company, its Board or its shareholders in connection therewith. Each of the Transaction Documents has been (or upon delivery will
have been) duly executed by the Company and is, or when delivered in accordance with the terms hereof or thereof, will constitute
the legal, valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except (i)
as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium, liquidation or similar
laws relating to, or affecting generally the enforcement of, creditors’ rights and remedies or by other equitable principles
of general application, (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other
equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law. There are
no shareholder agreements, voting agreements, voting trust agreements or similar agreements with respect to the Company’s
capital stock to which the Company is a party or, to the Company’s Knowledge, between or among any of the Company’s
shareholders.

(d)                      
No Conflicts. The execution, delivery and performance by the Company of the
Transaction Documents and the Additional Agreements and the consummation by the Company of the transactions contemplated hereby
or thereby (including, without limitation, the issuance of the Shares hereunder and the shares of Common Stock in accordance with
the Additional Agreements) do not and will not (i) conflict with or violate any provisions of the Company’s or the Bank’s
certificate or articles of incorporation, bylaws or otherwise result in a violation of the organizational documents of the Company
or the Bank, (ii) conflict with, or constitute a default (or an event that with notice or lapse of time or both would result in
a default) under, result in the creation of any Lien upon any of the properties or assets of the Company or the Bank under, or
give to others any rights of termination, amendment, acceleration or cancellation (with or without notice, lapse of time or both)
of, any Material Contract, or (iii) subject to receipt of the Required Approvals, conflict with or result in a violation of any
law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority to which
the Company is subject (including federal and state securities laws and the rules and regulations thereunder, assuming the correctness
of the representations and warranties made by the Purchasers herein, of any self-regulatory organization to which the Company
or its securities are subject, including all applicable Trading Markets), or by which any property or asset of the Company is
bound or affected, except in the case of clauses (ii) and (iii) such as would not have or reasonably be expected to have, individually
or in the aggregate, a Material Adverse Effect.

 

    	 	 9	 

     

    

(e)                    
Filings, Consents and Approvals. Neither the Company nor any of its Subsidiaries
is required to obtain any consent, waiver, authorization or order of, give any notice to, or make any filing or registration with,
any court or other federal, state, local or other governmental authority, self-regulatory organization (including any Trading
Market) or other Person in connection with the execution, delivery and performance by the Company of the Transaction Documents
(including, without limitation, the issuance of the Shares hereunder and the shares of Common Stock in accordance with the Additional
Agreements), other than (i) filings required by applicable state securities laws and (ii) the filing of a Notice of Exempt Offering
of Securities on Form D with the Commission under Regulation D of the Securities Act (collectively, the “Required Approvals”).
The Company is unaware of any facts or circumstances relating to the Company or the Bank which might prevent the Company from
obtaining or effecting any of the foregoing.

 

(f)                     
Issuance of the Shares. The issuance of the Shares has been duly authorized
and the Shares, when issued and paid for in accordance with the terms of the Transaction Documents, will be duly and validly issued,
fully paid and non-assessable and free and clear of all Liens, other than restrictions on transfer imposed by applicable securities
laws, and shall not be subject to preemptive or similar rights. Assuming the accuracy of the representations and warranties of
the Purchasers in this Agreement, the Shares will be issued in compliance with all applicable federal and state securities laws.

 

(g)                
Capitalization. The number of shares and type of all authorized, issued and
outstanding capital stock, options and other securities of the Company (whether or not presently convertible into or exercisable
or exchangeable for shares of capital stock of the Company) is set forth in Schedule 3.1(g) hereto. All of the outstanding
shares of capital stock of the Company are duly authorized, validly issued, fully paid and non-assessable, have been issued in
compliance in all material respects with all applicable federal and state securities laws, and none of such outstanding shares
was issued in violation of any preemptive rights or similar rights to subscribe for or purchase any capital stock of the Company.
Except as specified on Schedule 3.1(g): (i) no shares of the Company’s outstanding capital stock are subject to preemptive
rights or any other similar rights; (ii) there are no outstanding options, warrants, scrip, rights to subscribe to, calls or commitments
of any character whatsoever relating to, or securities or rights convertible into, or exercisable or exchangeable for, any shares
of capital stock of the Company or the Bank, or contracts, commitments, understandings or arrangements by which the Company or
the Bank is or may become bound to issue additional shares of capital stock of the Company or the Bank or options, warrants, scrip,
rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities or rights convertible into,
or exercisable or exchangeable for, any shares of capital stock of the Company or the Bank, other than those issued or granted
pursuant to compensatory plans, contracts or arrangements described on Schedule 3.1(g): (iii) [Note: deleted language is
covered at beginning of sentence] there are no material outstanding debt securities, notes, credit agreements, credit facilities
or other agreements, documents or instruments evidencing indebtedness of the Company or the Bank or by which the Company or the
Bank is bound; (iv) there are no agreements or arrangements under which the Company is obligated to register the sale of any of
the securities of the Company or the Bank under the Securities Act; (v) there are no outstanding securities or instruments of
the Company or the Bank that contain any redemption or similar provisions, and there are no contracts, commitments, understandings
or arrangements by which the Company or the Bank is or may become bound to redeem a security of the Company or the Bank; (vi)
the Company does not have any stock appreciation rights or “phantom stock” plans or agreements or any similar plan
or agreement; and (vii) neither the Company nor the Bank has any liabilities or obligations not disclosed in the Financial Statements,
which, individually or in the aggregate, will have or would reasonably be expected to have a Material Adverse Effect. There are
no securities or instruments issued by or to which the Company is a party containing anti-dilution or similar provisions that
will be triggered by the issuance of the Shares hereunder or the shares of Common Stock in accordance with the Additional Agreements.

    	 	 10	 

     

    

(h)         
Call Reports. The Company and the Bank filed all financial statements and financial
information required to be filed by it under the Federal Deposit Insurance Act and the BHC Act for the eighteen (18) months preceding
the date hereof (the foregoing materials, including the exhibits thereto and documents incorporated by reference therein, being
collectively referred to herein as the “Call Reports”), on a timely basis or has received a valid extension
of such time of filing and has filed any such Call Reports prior to the expiration of any such extension. As of their respective
filing dates, the Call Reports complied in all material respects with all statutes and applicable rules and regulations of the
applicable governmental agency or body, as the case may be.

		(i)	Financial
                                         Statements.

 

(i)                   
The financial statements of the Company and the Bank included in the Call Reports
comply in all material respects with applicable accounting requirements and the rules and regulations of the applicable government
agency with respect thereto as in effect at the time of filing. Such financial statements have been prepared in accordance with
GAAP applied on a consistent basis during the periods involved, except as may be otherwise specified in such financial statements
or the notes thereto or as required by the applicable government agency and except that unaudited financial statements may not
contain all footnotes required by GAAP, and fairly present in all material respects the balance sheet of the Company and the Bank
taken as a whole as of and for the dates thereof and the results of operations and cash flows for the periods then ended, subject,
in the case of unaudited statements, to normal, year-end audit adjustments.

 

(ii)                 
The Company has delivered to each Purchaser its audited financial statements as of
December 31, 2014 and for the fiscal year ended December 31, 2014 and its unaudited financial statements (including balance sheet,
income statement and statement of cash flows) as of September 30, 2015 and for the nine-month period ended September 30, 2015
(collectively, the “Financial Statements”). The Financial Statements have been prepared in accordance with
GAAP applied on a consistent basis throughout the periods indicated, except that the unaudited Financial Statements may not contain
all footnotes required by GAAP. The Financial Statements fairly present in all material respects the financial condition and operating
results of the Company as of the dates, and for the periods, indicated therein, subject in the case of the unaudited Financial
Statements to normal year-end audit adjustments. Except as set forth in the Financial Statements, the Company has no material
liabilities or obligations, contingent or otherwise, other than (i) liabilities incurred in the ordinary course of business subsequent
to September 30, 2015; (ii) obligations under contracts and commitments incurred in the ordinary course of business; and (iii)
liabilities and obligations of a type or nature not required under GAAP to be reflected in the Financial Statements, which, in
all such cases, individually and in the aggregate would not have a Material Adverse Effect. The Company maintains and will continue
to maintain a standard system of accounting established and administered in accordance with GAAP.

 

    	 	 11	 

     

    

(j)       Tax
Matters. The Company (i) has prepared and filed all foreign, federal, state and local income and all other tax returns, reports
and declarations required by any jurisdiction to which it is subject and such returns, reports and declarations are true, complete
and correct in all material respects, (ii) has paid all taxes and other governmental assessments and charges owed and due by the
Company (whether or not shown on any tax return), except those being contested in good faith and with respect to which adequate
reserves have been set aside on the books of the Company, (iii) has withheld or collected from each payment made to each of its
employees, independent contractors, shareholders, creditors and other third parties the amount of all taxes required to be withheld
or collected therefrom, and has paid the same to the proper authorized depositories or government authorities and (iv) has set
aside on its books provisions reasonably adequate for the payment of all taxes for periods subsequent to the periods to which
the above referenced returns, reports or declarations apply. There are no pending or active tax audits or proceedings or proposed
tax deficiencies or other claims for material unpaid taxes asserted with respect to the Company or its assets. There are no liens
for taxes (other than for taxes not yet due and payable) upon any of the assets of the Company. The Company has not received notice
of any claim made by an authority in any jurisdiction where the Company does not file tax returns that the Company is or may be
subject to taxation by that jurisdiction.

 

(k)       Material
Changes. Except as described on Schedule 3.1(k), since September 30, 2015, (i) there have been no events, occurrences
or developments that have had or would reasonably be expected to have, either individually or in the aggregate, a Material Adverse
Effect, (ii) the Company has not incurred any material liabilities (contingent or otherwise) other than (A) trade payables, accrued
expenses and other liabilities incurred in the ordinary course of business consistent with past practice and (B) liabilities not
required to be reflected in the Company’s financial statements pursuant to GAAP or required to be disclosed in filings made
with the Bank Regulatory Authorities, (iii) the Company has not altered materially its method of accounting or the manner in which
it keeps its accounting books and records, (iv) the Company has not declared or made any dividend or distribution of cash or other
property to its shareholders or purchased, redeemed or made any agreements to purchase or redeem any shares of its capital stock,
(v) the Company has not issued any equity securities to any officer, director or Affiliate, except Common Stock issued pursuant
to existing Company stock option plans or equity-based plans disclosed in the Financial Statements, (vi) there has not been any
material change or amendment to, or any waiver of any material right by the Company under, any Material Contract under which the
Company or any of its Subsidiaries is bound or subject, and to the Company’s Knowledge, there has not been a material increase
in the aggregate dollar amount of: (A) the Bank’s nonperforming loans (including nonaccrual loans and loans 90 days or more
past due and still accruing interest) or (B) the reserves or allowances established on the Company’s or Bank’s financial
statements with respect thereto.

 

    	 	 12	 

     

    

(1)                     
Environmental Matters. Neither the Company nor the Bank (i) is in violation of any statute, rule, regulation, decision
or order of any governmental agency or body or any court, domestic or foreign, relating to the use, disposal or release of hazardous
or toxic substances or relating to the protection or restoration of the environment or human exposure to hazardous or toxic substances
(collectively, “Environmental Laws”), (ii) owns or operates any real property contaminated with any substance
that is in violation of any Environmental Laws, (iii) is liable for any off-site disposal or contamination pursuant to any Environmental
Laws, or (iv) is subject to any claim relating to any Environmental Laws; in each case, which violation, contamination, liability
or claim has had or would reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect; and, to
the Company’s Knowledge, there is no pending or threatened investigation that might lead to such a claim.

 

(m)                 
Litigation. There is no Action which (i) adversely affects or challenges the
legality, validity or enforceability of any of the Transaction Documents or the issuance of the Shares or (ii) is reasonably likely
to have a Material Adverse Effect, individually or in the aggregate, if there were an unfavorable decision. Neither the Company
nor the Bank, nor any director or officer thereof, is or has been the subject of any Action involving a claim of violation of
or liability under federal or state securities laws or a claim of breach of fiduciary duty. There has not been, and to the Company’s
Knowledge there is not pending or contemplated, any investigation by the Commission involving the Company or any current or former
director or officer of the Company. There are no outstanding orders, judgments, injunctions, awards or decrees of any court, arbitrator
or governmental or regulatory body against the Company or any executive officers or directors of the Company in their capacities
as such, which individually or in the aggregate, would reasonably be expected to have a Material Adverse Effect.

(n)                      Employment
Matters. No labor dispute exists or, to the Company’s Knowledge, is imminent with respect to any of the employees
of the Company or the Bank which would have or reasonably be expected to have a Material Adverse Effect. None of the
Company’s or the Bank’s employees is a member of a union that relates to such employee’s relationship with
the Company or the Bank, and neither the Company nor the Bank is a party to a collective bargaining agreement, and each of
the Company and the Bank believes that its relationship with its employees is good. To the Company’s Knowledge, no
executive officer is, or is now expected to be, in violation of any material term of any employment contract,
confidentiality, disclosure or proprietary information agreement or non-competition agreement, or any other contract or
agreement or any restrictive covenant in favor of a third party, and to the Company’s Knowledge, the continued
employment of each such executive officer does not subject the Company or the Bank to any liability with respect to any of
the foregoing matters. Each of the Company and the Bank is in compliance with all U.S. federal, state, local and foreign laws
and regulations relating to employment and employment practices, terms and conditions of employment and wages and hours,
except where the failure to be in compliance would not have or reasonably be expected to have, individually or in the
aggregate, a Material Adverse Effect.

 

    	 	 13	 

     

    

(o)                  
Compliance. Neither the Company nor the Bank (i) is in default under or in violation of(and no event has occurred
that has not been waived that, with notice or lapse of time or both, would result in a default by the Company or the Bank under),
nor has the Company or the Bank received written notice of a claim that it is in default under or that it is in violation of,
any Material Contract (whether or not such default or violation has been waived), (ii) is in violation of any order of any court,
arbitrator or governmental body having jurisdiction over the Company, the Bank or their respective properties or assets, or (iii)
is in violation of, or in receipt of written notice that it is in violation of, any statute, rule, regulation, policy or guideline
or order of any governmental authority, self-regulatory organization (including the Principal Trading Market) applicable to the
Company or the Bank, or which would have the effect of revoking or limiting FDIC deposit insurance, except in each case as would
not have or reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect.

(p)                  
Regulatory Permits. Each of the Company and the Bank possesses all certificates, authorizations, consents and permits
issued by the appropriate federal, state, local or foreign regulatory authorities necessary to conduct its respective businesses
as currently conducted, except where the failure to possess such certificates, authorizations, consents or permits, individually
or in the aggregate, has not and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse
Effect (“Material Permits”), and (i) neither the Company nor the Bank has received any notice in writing of
Proceedings relating to the revocation or material adverse modification of any such Material Permits and (ii) the Company is unaware
of any facts or circumstances that would give rise to the revocation or material adverse modification of any Material Permits.

(q)                  
Title to Assets. Each of the Company and the Bank has good and marketable title to all real property and tangible
personal property owned by it which is material to the business of the Company and Bank, taken as a whole, in each case free and
clear of all Liens except such as do not materially affect the value of such property or do not interfere with the use made and
proposed to be made of such property by the Company and the Bank. Any real property and facilities held under lease by the Company
and the Bank are held by them under valid, subsisting and enforceable leases with such exceptions as are not material and do not
interfere with the use made and proposed to be made of such property and facilities by the Company and its Subsidiaries.

 

(r)                    
Patents and Trademarks. The Company and the Bank own, possess, license or have other rights to use all foreign and
domestic patents, patent applications, trade and service marks, trade and service mark registrations, trade names, copyrights,
inventions, trade secrets, technology, Internet domain names, know-how and other intellectual property (collectively, the “Intellectual
Property”) necessary for the conduct of their respective businesses as currently conducted or as proposed to be conducted
except where the failure to own, possess, license or have such rights would not have or reasonably be expected to have a Material
Adverse Effect. Except where such violations or infringements would not have or reasonably be expected to have, either individually
or in the aggregate, a Material Adverse Effect, (a) there are no rights of third parties to any such Intellectual Property; (b)
there is no infringement by third parties of any such Intellectual Property; (c) there is no pending or threatened Proceeding
by others challenging the Company’s and/or the Bank’s rights in or to any

such
Intellectual Property; (d) there is no pending or threatened Proceeding by others challenging the validity or scope of any such
Intellectual Property; and (e) there is no pending or threatened Proceeding by others that the Company and/or the Bank infringes
or otherwise violates any patent, trademark, service mark, trade name, copyright, invention, trade secret, technology, Internet
domain name, know-how or other proprietary rights of others.

 

    	 	 14	 

     

    

(s)                    
Insurance. The Company and the Bank are insured by insurers of recognized financial responsibility against such
losses and risks and in such amounts as the Company believes to be prudent and customary in the businesses and locations in which
the Company and the Bank are engaged. All premiums due and payable under all such policies and bonds have been timely paid, and
the Company and the Bank are in material compliance with the terms of such policies and bonds. Neither the Company nor the Bank
has received any notice of cancellation of any such insurance, nor, to the Company’s Knowledge, will it or the Bank be unable
to renew their respective existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar
insurers as may be necessary to continue its business at a cost that would be materially higher than their existing insurance
coverage.

 

(t)                    
Transactions With Affiliates and Employees. Other than the grant of stock options or other equity awards that are
not individually or in the aggregate material in amount and other than as disclosed in the audited Financial Statements, none
of the officers or directors of the Company and, to the Company’s Knowledge, none of the employees of the Company, is presently
a party to any transaction with the Company or to a presently contemplated transaction (other than for services as employees,
officers and directors) that would be required to be disclosed pursuant to GAAP in the audited Financial Statements.

 

(u)                   
Internal Accounting Controls. The Company maintains a system of internal accounting controls sufficient to provide
reasonable assurance that (i) transactions are executed in accordance with management’s general or specific authorizations,
(ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain
asset and liability accountability, (iii) access to assets or incurrence of liabilities is permitted only in accordance with management’s
general or specific authorization, and (iv) the recorded accountability for assets and liabilities is compared with the existing
assets and liabilities at reasonable intervals and appropriate action is taken with respect to any difference.

 

		(v)	Intentionally
                                         Omitted.

 

(w)                 
Certain Fees. No Person will have, as a result of the transactions contemplated by this Agreement, any valid right,
interest or claim against or upon the Company or a Purchaser for any commission, fee or other compensation pursuant to any agreement,
arrangement or understanding entered into by or on behalf of the Company, other than the Placement Agent with respect to the offer
and sale of the Shares (which placement agent fees are set forth in Schedule 3.1(w) and are being paid by the Company).
The Company shall indemnify, pay, and hold each Purchaser harmless against, any liability, loss or expense (including, without
limitation, attorneys’ fees and out-of-pocket expenses) arising in connection with any such right, interest or claim.

 

    	 	 15	 

     

    

(x)                  
Private Placement. Assuming the accuracy of the Purchasers’ representations and warranties set forth in Section
3.2 of this Agreement, no registration under the Securities Act is required for the offer and sale of the Shares by the Company
to the Purchasers under the Transaction Documents. The issuance and sale of the Shares hereunder does not contravene the rules
and regulations of the Principal Trading Market.

 

(y)                  
Registration Rights. No Person has any right to cause the Company lo effect the registration under the Securities
Act of any securities of the Company.

 

(z)                   
No Integrated Offering. Assuming the accuracy of the Purchasers’ representations and warranties set forth
in Section 3.2 of this Agreement, none of the Company, the Bank nor, to the Company’s Knowledge, any of its Affiliates or
any Person acting on its behalf has, directly or indirectly, at any time within the past six months, made any offers or sales
of any Company security or solicited any offers to buy any security under circumstances that would cause such offers and sales
to be integrated for purposes of Regulation D with the offer and sale by the Company of the Shares or that otherwise would cause
the exemption from registration under Regulation D to be unavailable in connection with the offer and sale by the Company of the
Shares.

 

(aa)Listing
and Maintenance Requirements. The Company is, and has no reason to believe that it will not in the foreseeable future continue
to be, in compliance in all material respects with the listing and maintenance requirements for continued trading of the Common
Stock on the Principal Trading Market.

 

(bb)Investment
Company. The Company is not, and immediately after receipt of payment for the Shares will not be, an “investment company,”
an “affiliated person” of, “promoter” for or “principal underwriter” for, an entity “controlled”
by an “investment company,” within the meaning of the Investment Company Act of 1940, as amended.

 

(cc)Unlawful
Payments. Neither the Company nor the Bank, nor any directors, officers, nor to the Company’s Knowledge, employees,
agents or other Persons acting at the direction of or on behalf of the Company or the Bank has, in the course of its actions for,
or on behalf of, the Company or the Bank: (a) directly or indirectly, used any corporate funds for unlawful contributions, gifts,
entertainment or other unlawful expenses relating to foreign or domestic political activity; (b) made any direct or indirect unlawful
payments to any foreign or domestic governmental officials or employees or to any foreign or domestic political parties or campaigns
from corporate funds; (c) violated any provision of the Foreign Corrupt Practices Act of 1977, as amended; or (d) made any other
unlawful bribe, rebate, payoff, influence payment, kickback or other material unlawful payment to any foreign or domestic government
official or employee.

 

(dd)
Application of Takeover Protections; Rights Agreements. The Company has not adopted any stockholder rights plan or similar
arrangement relating to accumulations of beneficial ownership of Common Stock or a change in control of the Company.

 

(ee)Disclosure.

 

    	 	 16	 

     

    

(i)                     
All of the disclosure furnished by or on behalf of the Company to the Purchasers regarding the Company and the Bank, their
respective businesses and the transactions contemplated hereby is true and correct in all material respects and does not contain
any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements made therein,
in light of the circumstances under which they were made, not misleading.

 

(ii)                   
The Company confirms that neither it nor any of its officers or directors nor any other Person acting on its or their behalf
has provided, and it has not authorized the Placement Agent to provide, any Purchaser or its respective agents or counsel with
any information that it believes constitutes or could reasonably be expected to constitute material, non-public information except
insofar as the existence, provisions and terms of the Transaction Documents and the proposed transactions hereunder and under
the Additional Agreements may constitute such information, all of which will be disclosed by the Company in the Press Release
as contemplated by Section 4.6 hereof. The Company understands and confirms that each of the Purchasers will rely on the foregoing
representations in effecting transactions in securities of the Company. No event or circumstance has occurred or information exists
with respect to the Company or the Bank or its or their business, properties, operations or financial conditions, which, under
applicable law, rule or regulation, requires public disclosure or announcement by the Company but which has not been so publicly
announced or disclosed.

 

(ff)Off
Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or the Bank)
and an unconsolidated or other off balance sheet entity that would have or reasonably be expected to have a Material Adverse Effect.

 

(gg)Acknowledgment
Regarding Purchase of Shares. The Company acknowledges and agrees that each of the Purchasers is acting solely in the capacity
of an arm’s length purchaser with respect to the Transaction Documents and the transactions contemplated hereby and thereby.
The Company further acknowledges that no Purchaser is acting as a financial advisor or fiduciary of the Company (or in any similar
capacity) with respect to the Transaction Documents and the transactions contemplated thereby and any advice given by any Purchaser
or any of their respective representatives or agents in connection with the Transaction Documents and the transactions contemplated
thereby is merely incidental to the Purchasers’ purchase of the Shares.

(hh)Absence
of Manipulation. The Company has not, and, to the Company’s Knowledge, no one acting on its behalf has, taken, directly
or indirectly, any action designed to cause or to result in the stabilization or manipulation of the price of any security of
the Company to facilitate the sale or resale of any of the Shares.

(ii)       OFAC.
Neither the Company nor the Bank nor, to the Company’s Knowledge, any director, officer, agent, employee, Affiliate or Person
acting on behalf of the Company or the Bank is currently subject to any U.S. sanctions administered by the Office of Foreign Assets
Control of the U.S. Treasury Department (“OFAC”); and the Company will not knowingly, directly or indirectly,
use the proceeds of the sale of the Shares, or lend, contribute or otherwise make available such proceeds to any Subsidiary, joint
venture partner or other Person or entity, towards any sales or operations in Cuba, Iran, Syria, Sudan, Myanmar or any other country
sanctioned by OFAC or for the purpose of financing the activities of any Person currently subject to any U.S. sanctions administered
by OFAC.

 

    	 	 17	 

     

    

(jj)          Money
Laundering Laws. The operations of each of the Company and the Bank are and have been conducted in substantial compliance
with the money laundering statutes of applicable jurisdictions, the rules and regulations thereunder and any related or similar
rules, regulations or guidelines, issued, administered or enforced by any applicable governmental agency (collectively, the “Money
Laundering Laws”) and to the Company’s Knowledge, no action, suit or proceeding by or before any court or governmental
agency, authority or body or any arbitrator involving the Company and/or the Bank with respect to the Money Laundering Laws is
pending or threatened.

 

(kk)        Compliance
with Certain Banking Regulations. The Company has no knowledge of any facts and circumstances, and has no reason to
believe that any facts or circumstances exist, that would cause the Bank: (i) to be deemed not to be in satisfactory
compliance with the Community Reinvestment Act and the regulations promulgated thereunder or to be assigned a CRA rating by
federal or state banking regulators of lower than “satisfactory”; (ii) to be deemed to be operating in violation,
in any material respect, of the Bank Secrecy Act of 1970 (or otherwise known as the “Currency and Foreign Transactions
Reporting Act”), the USA Patriot Act (or otherwise known as “Uniting and Strengthening America by Providing
Appropriate Tools Required to Intercept and Obstruct Terrorism Act of 2001”), any order issued with respect to
anti-money laundering by OFAC or any other anti-money laundering statute, rule or regulation; or (iii) to be deemed not to be
in satisfactory compliance, in any material respect, with all applicable privacy of customer information requirements
contained in any federal and state privacy laws and regulations as well as the provisions of all information security
programs adopted by the Bank.

(ll)           
No Additional Agreements. The Company has no other agreements or understandings (including, without limitation,
side letters) with any Purchaser or other Person to purchase Shares or other shares of Common Stock (including, without limitation,
pursuant to the Additional Agreements) on terms more favorable to such Person than as set forth herein.

 

(mm)      Reports,
Registrations and Statements. Since January 1, 2012, the Company and the Bank have filed all material reports, registrations
and statements, together with any required amendments thereto, that it was required to file with the Bank Regulatory Authorities
and any other applicable foreign, federal or state securities or banking authorities, including, without limitation, all financial
statements and financial information required to be filed by it under the Federal Deposit Insurance Act and the BHC Act. All such
reports and statements filed with any such regulatory body or authority are collectively referred to herein as the “Company
Reports.” All such Company Reports were filed on a timely basis or the Company or the Bank, as applicable, received
a valid extension of such time of filing and has filed any such Company Reports prior to the expiration of any such extension.
As of their respective dates, the Company Reports complied in all material respects with all the rules and regulations promulgated
by the Bank Regulatory Authorities and any other applicable foreign, federal or state securities or banking authorities, as the
case may be.

 

    	 	 18	 

     

    

(nn)
      Well Capitalized. As of September 30, 2015, the Bank met or exceeded the standards necessary to be considered
“well capitalized” under the FDIC’s regulatory framework for prompt corrective action.

(oo)       Agreements
with Regulatory Agencies. Neither the Company nor the Bank is subject to any cease-and-desist or other similar order or enforcement
action issued by, or is a party to any written agreement, consent agreement or memorandum of understanding with, or is a party
to any commitment letter or similar undertaking to, or is subject to any capital directive by, or since December 31, 2011, has
adopted any board resolutions at the request of, any governmental entity that currently restricts in any material respect the
conduct of its business or that in any material manner relates to its capital adequacy, its liquidity and funding policies and
practices, its ability to pay dividends, its credit, risk management or compliance policies, its internal controls, its management
or its operations or business (each item in this sentence, a “Regulatory Agreement”), nor has the Company or
any Subsidiary been advised since December 31, 2011 by any governmental entity that it is considering issuing, initiating, ordering,
or requesting any such Regulatory Agreement. The Company and the Bank are in compliance in all material respects with each Regulatory
Agreement to which it is party or subject, and neither the Company nor the Bank has received any notice from any governmental
entity indicating that either the Company or the Bank is not in compliance in all material respects with any such Regulatory Agreement.

Each
of the Company and the Bank has properly administered all accounts for which it acts as a fiduciary, including accounts for which
it serves as a trustee, agent, custodian, personal representative, guardian, conservator or investment advisor, in accordance
with the terms of the governing documents, applicable federal and state law and regulation and common law. None of the Company,
the Bank or any director, officer or employee of the Company or the Bank has committed any breach of trust or fiduciary duty with
respect to any such fiduciary account and the accountings for each such fiduciary account are true and correct and accurately
reflect the assets of such fiduciary account.

(pp)          No
General Solicitation or General Advertising. Neither the Company nor any Person acting on its behalf has engaged or will engage
in any form of general solicitation or general advertising (within the meaning of Regulation D under the Securities Act) in connection
with any offer or sale of the Shares.

(qq)           Mortgage
Banking Business. Except as has not had and would not reasonably be expected to have a Material Adverse Effect:

(i)                       
Each of the Company and the Bank has complied with, and all documentation in connection with the origination, processing,
underwriting and credit approval of any mortgage loan originated, purchased or serviced by the Company or the Bank satisfied,
(A) all applicable federal, state and local laws, rules and regulations with respect to the origination, insuring, purchase, sale,
pooling, servicing, subservicing, or filing of claims in connection with mortgage loans, including all laws relating to real estate
settlement procedures, consumer credit protection, truth in lending laws, usury limitations, fair housing, transfers of servicing,
collection practices, equal credit opportunity and adjustable rate mortgages, (B) the responsibilities and obligations relating
to mortgage loans set forth in any agreement between the Company or the Bank and any Agency, Loan Investor or Insurer, (C) the
applicable rules, regulations, guidelines, handbooks and other requirements of any Agency, Loan Investor or Insurer and (D) the
terms and provisions of any mortgage or other collateral documents and other loan documents with respect to each mortgage loan;
and

 

    	 	 19	 

     

    

(ii)                  
No Agency, Loan Investor or Insurer has (A) claimed in writing that the Company or the Bank has violated or has not complied
with the applicable underwriting standards with respect to mortgage loans sold by the Company or the Bank to a Loan Investor or
Agency, or with respect to any sale of mortgage servicing rights to a Loan Investor, (B) imposed in writing restrictions on the
activities (including commitment authority) of the Company or the Bank or (C) indicated in writing to the Company or the Bank
that it has terminated or intends to terminate its relationship with the Company or the Bank for poor performance, poor loan quality
or concern with respect to the Company’s or the Bank’s compliance with laws,

 

For
purposes of this Section 3.1(qq): (A) “Agency” means the Federal Housing Administration, the Federal Home Loan
Mortgage Corporation, the Farmers Home Administration (now known as Rural Housing and Community Development Services), the Federal
National Mortgage Association, the United States Department of Veterans’ Affairs, the Rural Housing Service of the U.S.
Department of Agriculture or any other federal or state agency with authority to (i) determine any investment, origination, lending
or servicing requirements with regard to mortgage loans originated, purchased or serviced by the Company or any of its Subsidiaries
or (ii) originate, purchase, or service mortgage loans, or otherwise promote mortgage lending, including state and local housing
finance authorities; (B) “Loan Investor” means any person (including an Agency) having a beneficial interest
in any mortgage loan originated, purchased or serviced by the Company or any of its Subsidiaries or a security backed by or representing
an interest in any such mortgage loan; and (C) “Insurer” means a person who insures or guarantees for the benefit
of the mortgagee all or any portion of the risk of loss upon borrower default on any of the mortgage loans originated, purchased
or serviced by the Company or any of its Subsidiaries, including the Federal Housing Administration, the United States Department
of Veterans’ Affairs, the Rural Housing Service of the U.S. Department of Agriculture and any private mortgage insurer,
and providers of hazard, title or other insurance with respect to such mortgage loans or the related collateral.

 

(rr)Risk
Management Instruments. Except as has not had or would not reasonably be expected to have a Material Adverse Effect, since
January 1, 2012, all material derivative instruments, including, swaps, caps, floors and option agreements, whether entered into
for the Company’s own account, or for the account of one or more of the Company Subsidiaries, were entered into (1) only
in the ordinary course of business, (2) in accordance with prudent practices and in all material respects with all applicable
laws, rules, regulations and regulatory policies and (3) with counterparties believed to be financially responsible at the time;
and each of them constitutes the valid and legally binding obligation of the Company or one of the Company Subsidiaries, enforceable
in accordance with its terms. Neither the Company nor the Company Subsidiaries, nor, to the knowledge of the Company, any other
party thereto, is in breach of any of its material obligations under any such agreement or arrangement.

 

    	 	 20	 

     

    

(ss)ERISA.
The Company is in compliance in all material respects with all presently applicable provisions of the Employee Retirement
Income Security Act of 1974, as amended, including the regulations and published interpretations thereunder (herein called “ERISA”);
no “reportable event” (as defined in ERISA) has occurred with respect to any “pension plan” (as defined
in ERISA) for which the Company would have any liability; the Company has not incurred and does not expect to incur liability
under (i) Title IV of ERISA with respect to termination of, or withdrawal from, any “pension plan”; or (ii) Sections
412 or 4971 of the Internal Revenue Code of 1986, as amended, including the regulations and published interpretations thereunder
(the “Code”); and each “Pension Plan” for which the Company would have liability that is intended
to be qualified under Section 40l(a) of the Code is so qualified in all material respects and nothing has occurred, whether by
action or by failure to act, which would cause the loss of such qualification.

 

(tt)Shell
Company Status. The Company is not, and has never been, an issuer identified in Rule 144(i)(l).

(uu)Nonperforming
Assets. Except as would not reasonably be expected to have a Material Adverse Effect to the Company’s knowledge, the
Company believes that the Bank will be able to fully and timely collect substantially all interest, principal or other payments
when due under its loans, leases and other assets that are not classified as nonperforming and such belief is reasonable under
all the facts and circumstances known to the Company and Bank, and the Company believes that the amount of reserves and allowances
for loan and lease losses and other nonperforming assets established on the Company’s and Bank’s financial statements
is adequate and such belief is reasonable under all the facts and circumstances known to the Company and Bank.

(vv)Change
in Control. The issuance of the Shares to the Purchasers as contemplated by this Agreement and the issuance of shares of Common
Stock as contemplated by the Additional Agreements will not trigger any rights under any “change of control” provision
in any of the agreements to which the Company or any of its Subsidiaries is a party, including any employment, “change in
control,” severance or other compensatory agreements and any benefit plan, which results in payments to the counterparty
or the acceleration of vesting of benefits.

 

(ww)Common
Control. The Company is not and, to the Company’s Knowledge after giving effect to the offering and sale of the Shares,
will not be under the control (as defined in the BHC Act and the Federal Reserve’s Regulation Y (12 CFR Part 225) (“BHC
Act Control”) of any company (as defined in the BHC Act and the Federal Reserve’s Regulation Y). The Company is
not in BHC Act Control of any federally insured depository institution other than the Bank. The Bank is not under the BHC Act
Control of any company (as defined in the BHC Act and the Federal Reserve’s Regulation Y) other than Company. Neither the
Company nor the Bank controls, in the aggregate, more than five percent of the outstanding voting class, directly or indirectly,
of any federally insured depository institution. The Bank is not subject to the liability of any commonly controlled depository
institution pursuant to Section 5(e) of the Federal Deposit Insurance Act (12 U.S.C. § 1815(e)).

 

    	 	 21	 

     

    

(xx)       No
“Bad Actor” Disqualification. The Company has exercised reasonable care, in accordance with Commission rules and
guidance, and has conducted a factual inquiry including the procurement of relevant questionnaires from each Covered Person (as
defined below) or other means, the nature and scope of which reflect reasonable care under the relevant facts and circumstances,
to determine whether any Covered Person (as defined below) is subject to any of the “bad actor” disqualifications
described in Rule 506(d)(1)(i) to (viii) under the Securities Act (“Disqualification Events”). To the Company’s
knowledge, after conducting such sufficiently diligent factual inquiries, no Covered Person is subject to a Disqualification Event,
except for a Disqualification Event covered by Rule 506(d)(2) or (d)(3) under the Securities Act. The Company has complied, to
the extent applicable, with any disclosure obligations under Rule 506(e) under the Securities Act. “Covered Persons”
are those persons specified in Rule 506(d)(1) under the Securities Act, including the Company; any predecessor or affiliate
of the Company; any director, executive officer, other officer participating in the offering, general partner or managing member
of the Company; any beneficial owner of 20% or more of the Company’s outstanding voting equity securities, calculated on
the basis of voting power; any promoter (as defined in Rule 405 under the Securities Act) connected with the Company in any capacity
at the time of the sale of the Securities; and any person that has been or will be paid (directly or indirectly) remuneration
for solicitation of purchasers in connection with the sale of the Securities (a “Solicitor”), any general partner
or managing member of any Solicitor, and any director, executive officer or other officer participating in the offering of any
Solicitor or general partner or managing member of any Solicitor.

3.2                   
Representations and Warranties of the Purchasers. Each Purchaser hereby, for itself and for no other Purchaser,
represents and warrants as of the date hereof and as of the Closing Date to the Company as follows:

(a)                   
Organization; Authority. If such Purchaser is an entity, it is duly organized, validly existing and in good standing
under the laws of the jurisdiction of its organization with the requisite corporate, partnership, limited liability company or
other power and authority to enter into and to consummate the transactions contemplated by the applicable Transaction Documents
and otherwise to carry out its obligations hereunder and thereunder. If such Purchaser is an entity, the execution and delivery
of this Agreement and performance by such Purchaser of the transactions contemplated by this Agreement have been duly authorized
by all necessary corporate or, if such Purchaser is not a corporation, such partnership, limited liability company or other applicable
like action, on the part of such Purchaser. If such Purchaser is an entity, this Agreement has been duly executed by such Purchaser,
and when delivered by such Purchaser in accordance with the terms hereof, will constitute the valid and legally binding obligation
of such Purchaser, enforceable against it in accordance with its terms, except as such enforceability may be limited by applicable
bankruptcy, insolvency, reorganization, moratorium, liquidation or similar laws relating to, or affecting generally the enforcement
of, creditors’ rights and remedies or by other equitable principles of general application.

 

    	 	 22	 

     

    

(b)                    
No Conflicts. The execution, delivery and performance by such Purchaser of this Agreement and the consummation by
such Purchaser of the transactions contemplated hereby will not (i) result in a violation of the organizational documents of such
Purchaser (if such Purchaser is an entity), (ii) conflict with, or constitute a default (or an event which with notice or lapse
of time or both would become a default) under, or give to others any rights of termination, amendment, acceleration or cancellation
of, any agreement, indenture or instrument to which such Purchaser is a party, or (iii) result in a violation of any Jaw, rule,
regulation, order, judgment or decree (including federal and state securities laws) applicable to such Purchaser, except in the
case of clauses (ii) and (iii) above, for such conflicts, defaults, rights or violations which would not, individually or in the
aggregate, reasonably be expected to have a material adverse effect on the ability of such Purchaser to perform its obligations
hereunder.

 

(c)                     
Investment Intent. Such Purchaser understands that the Shares are “restricted securities” and have not
been registered under the Securities Act or any applicable state securities law and is acquiring the Shares as principal for its
own account and not with a view to, or for distributing or reselling such Shares or any part thereof in violation of the Securities
Act or any applicable state securities laws, provided, however, that by making the representations herein, such Purchaser
does not agree to hold any of the Shares for any minimum period of time and reserves the right at all times to sell or otherwise
dispose of all or any part of such Shares pursuant to an effective registration statement under the Securities Act or under an
exemption from such registration and in compliance with applicable federal and state securities Jaws. Such Purchaser is acquiring
the Shares hereunder in the ordinary course of its business. Such Purchaser does not presently have any agreement, plan or understanding,
directly or indirectly, with any Person to distribute or effect any distribution of any of the Shares to or through any Person.

(d)                     
Purchaser Status. At the time such Purchaser was offered the Shares, it was, and at the date hereof it is, an “accredited
investor” as defined in Rule 50l(a) under the Securities Act.

 

(e)                      
General Solicitation. Such Purchaser is not purchasing the Shares as a result of any advertisement, article, notice
or other communication regarding the Shares published in any newspaper, magazine or similar media or broadcast over television
or radio or presented at any seminar or any other general advertisement.

(f)                       
Experience of Such Purchaser. Such Purchaser, either alone or together with its representatives, has such knowledge,
sophistication and experience in business and financial matters so as to be capable of evaluating the merits and risks of the
prospective investment in the Shares, and has so evaluated the merits and risks of such investment. Such Purchaser is able to
bear the economic risk of an investment in the Shares and, at the present time, is able to afford a complete Joss of such investment.

(g)                      
Access to Information. Such Purchaser acknowledges that it has been afforded (i) the opportunity to ask such questions
as it has deemed necessary of, and to receive answers from, representatives of the Company concerning the terms and conditions
of the offering of the Shares and the merits and risks of investing in the Shares; (ii) access to information about the Company
and the Bank and their respective financial condition, results of operations, business, properties, management and prospects sufficient
to enable it to evaluate its investment; and (iii) the opportunity to obtain such additional information that the Company possesses
or can acquire without unreasonable effort or expense that is necessary to make an informed investment decision with respect to
the investment. Neither such inquiries nor any other investigation conducted by or on behalf of such Purchaser or its representatives
or counsel shall modify, amend or affect such Purchaser’s right to rely on the truth, accuracy and completeness of the Financial
Statements and Call Reports and the Company’s representations and warranties contained in the Transaction Documents. Such
Purchaser has sought such accounting, legal and tax advice as it has considered necessary to make an informed decision with respect
to its acquisition of the Shares.

    	 	 23	 

     

    

(h)                   
Brokers and Finders. Other than the Placement Agent with respect to the Company (which fees are to be paid by the
Company), no Person will have, as a result of the transactions contemplated by this Agreement, any valid right, interest or claim
against or upon the Company or any Purchaser for any commission, fee or other compensation pursuant to any agreement, arrangement
or understanding entered into by or on behalf of the Purchaser.

 

(i)                     
Independent Investment Decision. Such Purchaser has independently evaluated the merits of its decision to purchase
Shares pursuant to the Transaction Documents, and such Purchaser confirms that it has not relied on the advice of any other Purchaser’s
business and/or legal counsel in making such decision. Such Purchaser understands that nothing in this Agreement or any other
materials presented by or on behalf of the Company to the Purchaser in connection with the purchase of the Shares constitutes
legal, tax or investment advice. Such Purchaser has consulted such legal, tax and investment advisors as it, in its sole discretion,
has deemed necessary or appropriate in connection with its purchase of the Shares. Such Purchaser understands that the Placement
Agent has acted solely as the agent of the Company in this placement of the Shares and such Purchaser has not relied on the business
or legal advice of the Placement Agent or any of its agents, counsel or Affiliates in making its investment decision hereunder,
and confirms that none of such Persons has made any representations or warranties to such Purchaser in connection with the transactions
contemplated by the Transaction Documents.

 

(j)                     
Reliance on Exemptions. Such Purchaser understands that the Shares being offered and sold to it in reliance on specific
exemptions from the registration requirements of U.S. federal and state securities laws and that the Company is relying in part
upon the truth and accuracy of, and such Purchaser’s compliance with, the representations, warranties, agreements, acknowledgements
and understandings of such Purchaser set forth herein in order to determine the availability of such exemptions and the eligibility
of such Purchaser to acquire the Shares.

 

(k)                   
No Governmental Review. Such Purchaser understands that no U.S. federal or state agency or any other government
or governmental agency has passed on or made any recommendation or endorsement of the Shares or the fairness or suitability of
the investment in the Shares nor have such authorities passed upon or endorsed the merits of the offering of the Shares.

 

    	 	 24	 

     

    

(l)                     Residency.
Such Purchaser’s residence (if an individual) or office in which its investment decision with respect to the Shares
was made (if an entity) are located at the address immediately below such Purchaser’s name on its signature page hereto.

3.3                   
The Company and each of the Purchasers acknowledge and agree that no party to this Agreement has made or makes any representations
or warranties with respect to the transactions contemplated hereby other than those specifically set forth in this Article III
and the Transaction Documents.

 

ARTICLE
IV

OTHER
AGREEMENTS OF THE PARTIES

 

		4.1	Transfer
                                         Restrictions.

(a)                     
Compliance with Laws. Notwithstanding any other provision of this Article IV, each Purchaser covenants that the
Shares may be disposed of only pursuant to an effective registration statement under, and in compliance with the requirements
of, the Securities Act, or pursuant to an available exemption from, or in a transaction not subject to, the registration requirements
of the Securities Act, and in compliance with any applicable state, federal or foreign securities laws. In connection with any
transfer of the Shares other than (i) pursuant to an effective registration statement, (ii) to the Company or (iii) pursuant to
Rule 144 (provided that the transferor provides the Company with reasonable assurances (in the form of a seller representation
letter and, if applicable, a broker representation letter) that such securities may be sold pursuant to such rule), the Company
may require the transferor thereof to provide to the Company and the Transfer Agent, at the transferor’s expense, an opinion
of counsel selected by the transferor and reasonably acceptable to the Company and the Transfer Agent, the form and substance
of which opinion shall be reasonably satisfactory to the Company and the Transfer Agent, to the effect that such transfer does
not require registration of such Shares under the Securities Act.

 

(b)                     
Legends. Certificates evidencing the Shares shall bear any legend as required by the “blue sky” laws
of any state and a restrictive legend in substantially the following form, until such time as they are not required under Section
4.1(c) or applicable law:

 

THESE
SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR APPLICABLE
STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN
EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OR (B) AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION
NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS OR
BLUE SKY LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE COMPANY AND ITS TRANSFER AGENT OR (II)
UNLESS SOLD PURSUANT TO RULE 144 UNDER SAID ACT (PROVIDED THAT THE TRANSFEROR PROVIDES THE COMPANY WITH REASONABLE ASSURANCES
(IN THE FORM OF A SELLER REPRESENTATION LETTER AND, IF APPLICABLE, A BROKER REPRESENTATION LETTER) THAT THE SECURITIES MAY BE
SOLD PURSUANT TO SUCH RULE). NO REPRESENTATION IS MADE BY THE ISSUER AS TO THE AVAILABILITY OF THE EXEMPTION PROVIDED BY RULE
144 UNDER THE SECURITIES ACT FOR RESALES OF THESE SECURITIES.

    	 	 25	 

     

    

(c)                   
Removal of Legends. The restrictive legend set forth in Section 4.1(b) above shall be removed and the Company shall
issue a certificate without such restrictive legend or any other restrictive legend to the holder of the applicable Shares upon
which it is stamped or issue to such holder by electronic delivery at the applicable balance account at DTC, if (i) such Shares
are registered for resale under the Securities Act, (ii) such Shares are sold or transferred pursuant to Rule 144, or (iii) such
Shares are eligible for sale under Rule 144, without the requirement for the Company to be in compliance with the current public
information required under Rule 144(c)(l) (or Rule 144(i)(2), if applicable) as to such securities and without volume or manner-of-sale
restrictions. Upon Rule 144 becoming available for the resale of Shares, without the requirement for the Company to be in compliance
with the current public information required under Rule I 44(c)(I) (or Rule I 44(i)(2), if applicable) as to the Shares and without
volume or manner-of-sale restrictions, the Company shall instruct the Transfer Agent to remove the legend from the Shares and
shall cause its counsel to issue any legend removal opinion required by the Transfer Agent. Any fees (with respect to the Transfer
Agent, Company counsel or otherwise) associated with the issuance of such opinion or the removal of such legend shall be borne
by the Company. If a legend is no longer required pursuant to the foregoing, the Company will no later than five (5) Trading Days
following the delivery by a Purchaser to the Transfer Agent (with notice to the Company) of a legended certificate or instrument
representing such Shares (endorsed or with stock powers attached, signatures guaranteed, and otherwise in form necessary to affect
the reissuance and/or transfer) and a representation letter to the extent required by Section 4.1(a), deliver or cause to be delivered
to such Purchaser a certificate or instrument (as the case may be) representing such Shares that is free from all restrictive
legends. The Company may not make any notation on its records or give instructions to the Transfer Agent that enlarge the restrictions
on transfer set forth in this Section 4.1(c). Certificates for Shares free from all restrictive legends may be transmitted by
the Transfer Agent to the Purchasers by crediting the account of the Purchaser’s prime broker with DTC as directed by such
Purchaser.

 

(d)                  
Acknowledgement. Each Purchaser hereunder acknowledges its primary responsibilities under the Securities Act and
accordingly will not sell or otherwise transfer the Shares or any interest therein without complying with the requirements of
the Securities Act.

 

    	 	 26	 

     

    

4.2                    
Acknowledgment of Dilution. The Company acknowledges that the issuance of the Shares may result in dilution of the
outstanding shares of Common Stock. The Company further acknowledges that its obligations under the Transaction Documents, including
without limitation its obligation to issue the Shares pursuant to the Transaction Documents, are unconditional and absolute and
not subject to any right of set off, counterclaim, delay or reduction, regardless of the effect of any such dilution or any claim
the Company may have against any Purchaser and regardless of the dilutive effect that such issuance may have on the ownership
of the other shareholders of the Company.

4.3                   
SEC Reporting Company. By no later than forty-two (42) months following the Closing (provided any Purchaser, together
with its Affiliates and, for purposes of this Section 4.3 only, Persons who share a common discretionary investment adviser with
such Purchaser, own 4.9% or more of all of the outstanding shares of Common Stock at such time), the Company shall cause itself
(i) to be subject to the periodic reporting requirements of Section 13 (by having its Common Stock registered under Section 12
of the Exchange Act) or Section IS(d) of the Exchange Act and (ii) to use its best efforts to have its Common Stock listed on
the New York Stock Exchange, the NYSE MKT, the NASDAQ Global Select Market, the NASDAQ Global Market or the NASDAQ Capital Market.

 

4.4                    
Form D and Blue Sky. The Company agrees to timely file a Form D with respect to the Shares as required under Regulation
D. The Company, on or before the Closing Date, shall take such action as the Company shall reasonably determine is necessary in
order to obtain an exemption for or to qualify the Shares for sale to the Purchasers at the Closing pursuant to this Agreement
under applicable securities or “Blue Sky” laws of the states of the United States (or to obtain an exemption from
such qualification). The Company shall make all filings and reports relating to the offer and sale of the Shares required under
applicable securities or “Blue Sky” laws of the states of the United States following the Closing Date.

 

4.5                    
No Integration. The Company shall not, and shall use its commercially reasonable efforts to ensure that no Affiliate
of the Company shall, sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined
in Section 2 of the Securities Act) that will be integrated with the offer or sale of the Shares in a manner that would require
the registration under the Securities Act of the sale of the Shares to the Purchasers.

 

4.6                    
Securities Laws Disclosure; Publicity. By 9:00 a.m., New York City time, on the Business Day immediately following
execution of this Agreement, the Company shall issue one or more press releases (collectively, the “Press Release”)
reasonably acceptable to the Purchasers disclosing all material terms of the transactions contemplated hereby and by the Additional
Agreements and any other material, nonpublic information that the Company may have provided any Purchaser at any time prior to
the filing of the Press Release. If, following public disclosure of the transactions contemplated hereby, this Agreement terminates
prior to Closing, the Company shall issue a press release disclosing such termination by 9:00 a.m., New York City time, on the
first Business Day following the date of such termination. Notwithstanding the foregoing, the Company shall not publicly disclose
the name of any Purchaser or any Affiliate or investment adviser of any Purchaser, or include the name of any Purchaser or any
Affiliate or investment adviser of any Purchaser in any press release or in any filing with the Commission or any regulatory agency
or Trading Market, without the prior written consent of such Purchaser, except to the extent such disclosure is required by law,
in which case the Company shall provide the Purchasers with prior written notice of such disclosure permitted under this subclause
(ii). From and after the issuance of the Press Release, no Purchaser shall be in possession of any material, non-public information
received from the Company, the Bank or any of their respective officers, directors or employees or the Placement Agent.

 

    	 	 27	 

     

    

4.7                   
Non-Public Information. Except with the express written consent of such Purchaser and unless prior thereto such
Purchaser shall have executed a written agreement regarding the confidentiality and use of such information, the Company shall
not, and shall cause the Bank and each of their respective officers, directors, employees and agents, not to, and each Purchaser
shall not directly solicit the Company, the Bank or any of their respective officers, directors, employees or agents to provide
any Purchaser with any material, non-public information regarding the Company or the Bank from and after the filing of the Press
Release.

 

		4.8	Indemnification.

 

(a)                   
Indemnification of Purchasers. The Company will indemnify and hold each Purchaser and its directors, officers, shareholders,
members, partners, employees, agents and investment advisers (and any other Persons with a functionally equivalent role of a Person
holding such titles notwithstanding a lack of such title or any other title), each Person who controls such Purchaser (within
the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, shareholders,
agents, members, partners, employees, agents and investment advisers (and any other Persons with a functionally equivalent role
of a Person holding such titles notwithstanding a lack of such title or any other title) of such controlling person (each, an
“Indemnified Person”) harmless from any and all losses, liabilities, obligations, claims, contingencies, damages,
costs and expenses, including all judgments, amounts paid in settlements, court costs and reasonable attorneys’ fees and
costs of investigation that any such Indemnified Person may suffer or incur as a result of (i) any breach of any of the representations,
warranties, covenants or agreements made by the Company in this Agreement or in the other Transaction Documents or (ii) any action
instituted against an Indemnified Person in any capacity, or any of them or their respective Affiliates, by any shareholder of
the Company or other third party who is not an Affiliate of such Indemnified Person, with respect to any of the transactions contemplated
by this Agreement. The Company will not be liable to any Indemnified Person under this Agreement to the extent, but only to the
extent that a loss, claim, damage or liability is directly attributable to any Indemnified Person’s breach of any of the
representations, warranties, covenants or agreements made by such Indemnified Person in this Agreement or in the other Transaction
Documents.

 

(b)                   
Conduct of Indemnification Proceedings. Promptly after receipt by any Indemnified Person of any notice of any demand,
claim or circumstances which would or might give rise to a claim or the commencement of any Proceeding in respect of which indemnity
may be sought pursuant to Section 4.8(a), such Indemnified Person shall promptly notify the Company in writing and the Company
shall assume the defense thereof, including the employment of counsel reasonably satisfactory to such Indemnified Person, and
shall assume the payment of all fees and expenses; provided that the failure of any Indemnified Person so to notify the
Company shall not relieve the Company of its obligations hereunder except to the extent that such failure shall have materially
and adversely prejudiced the Company (as finally determined by a court of competent jurisdiction, which determination is not subject
to appeal or further review). In any such Proceeding, any Indemnified Person shall have the right to retain its own counsel, but
the fees and expenses of such counsel shall be at the expense of such Indemnified Person unless: (i) the Company and the Indemnified
Person shall have mutually agreed to the retention of such counsel; (ii) the Company shall have failed promptly to assume the
defense of such Proceeding and to employ counsel reasonably satisfactory to such Indemnified Person in such Proceeding; or (iii)
in the reasonable judgment of counsel to such Indemnified Person, representation of both parties by the same counsel would be
inappropriate due to actual or potential differing interests between them, provided, however, that the Company shall not be required
to pay for more than two separate counsel for all Indemnified Persons. The Company shall not be liable for any settlement of any
Proceeding effected without its written consent, which consent shall not be unreasonably withheld, delayed or conditioned. Without
the prior written consent of the Indemnified Person, the Company shall not effect any settlement of any pending or threatened
Proceeding in respect of which any Indemnified Person is or could have been a party and indemnity could have been sought hereunder
by such Indemnified Person, unless such settlement includes an unconditional release of such Indemnified Person from all liability
arising out of such Proceeding.

    	 	 28	 

     

    

4.9                     
Listing of Common Stock. The Company will use its reasonable best efforts to list the Shares for quotation on the
Principal Trading Market and maintain the listing of the Common Stock on the Principal Trading Market.

4.10                  
Use of Proceeds. The Company intends to use the net proceeds from the sale of the Shares hereunder for the purpose
of [increasing its capital and] for general corporate purposes[, including enabling the Bank to continue to meet its regulatory
capital requirements].

 

4.11                  
Ownership Limitation. No Purchaser shall be entitled to purchase a number of Shares that would cause such Purchaser,
together with any other person whose Company securities would be aggregated with such Purchaser’s Company securities for
purposes of any banking regulation or law, to collectively be deemed to own, control or have the power to vote shares of Common
Stock which would represent more than 9.9% of the number of shares of Common Stock issued and outstanding (based on the number
of outstanding shares as of the Closing Date).

4.12                   
Certain Transactions. The Company will not merge or consolidate into, or sell, transfer or lease all or substantially
all of its property or assets to, any other party unless the successor, transferee or lessee party, as the case may be (if not
the Company), expressly assumes the due and punctual performance and observance of each and every covenant and condition of this
Agreement to be performed and observed by the Company.

4.13                   
No Change of Control. The Company shall use reasonable best efforts to obtain all necessary irrevocable waivers,
adopt any required amendments and make all appropriate determinations so that the issuance of the Shares to the Purchasers will
not trigger a “change of control” or other similar provision in any of the agreements to which the Company or any
of its Subsidiaries is a party, including without limitation any employment, “change in control,” severance or other
agreements and any benefit plan, which results in payments to the counterparty or the acceleration of vesting of benefits.

 

    	 	 29	 

     

    
		4.14	Preemptive
                                         Rights.

 

(a)                   
For so long as a Purchaser, together with its Affiliates and, for purposes of this Section 4.14 only, Persons who share
a common discretionary investment adviser with such Purchaser, owns 4.9% or more of all of the outstanding shares of Common Stock
(determined at the time of, and before giving effect to, any issuances triggering provisions of this Section) (each, a “Qualified
Purchaser”), if the Company offers to sell Covered Securities (as defined below) in a public or private offering of
Covered Securities (a “Qualified Offering”), each Qualified Purchaser shall be afforded the opportunity to
acquire from the Company, for the same price and on the same terms as such Covered Securities are offered, in the aggregate up
to the amount of Covered Securities required to enable it to maintain its Qualified Purchaser Percentage Interest. “Qualified
Purchaser Percentage Interest” means, as of any date of determination, the percentage equal to (A) the aggregate number
of shares of Common Stock then held by the Qualified Purchaser as of the date of determination divided by (B) the total number
of outstanding shares of Common Stock as of such date. “Covered Securities” means Common Stock and any rights,
options or warrants to purchase or securities convertible into or exercisable or exchangeable for Common Stock, other than (i)
any Common Stock or other securities issuable upon the exercise or conversion of any securities of the Company outstanding as
of the date hereof; (ii) pursuant to the granting or exercise of employee stock options or other stock incentives pursuant to
the Company’s stock incentive plans approved by the Board or the issuance of stock pursuant to the Company’s employee
stock purchase plan approved by the Board or similar plan where stock is being issued or offered to a trust, other entity or otherwise,
for the benefit of any employees, officers or directors of the Company, in each case in the ordinary course of providing incentive
compensation; (iii) issuances of capital stock as full or partial consideration for a merger, acquisition, joint venture, strategic
alliance, license agreement or other similar non-financing transaction; and (iv) issuance of capital stock for consideration other
than cash (or an agreement, including without limitation, a note, to pay cash).

(b)                
Prior to making any Qualified Offering of Covered Securities, the Company shall give each Qualified Purchaser written notice
of its intention to make such an offering, describing, to the extent then known, the anticipated amount of securities, and other
material terms then known to the Company upon which the Company proposes to oiler the same (such notice, a “Qualified
Offering Notice”). The Company shall deliver such notice only to the individuals identified on such Qualified Purchaser’s
signature page hereto, and shall not communicate the information to anyone else acting on behalf of such Qualified Purchaser without
the consent of one of the designated individuals. Each Qualified Purchaser shall then have 10 days after receipt of the Qualified
Offering Notice (the “Offer Period”) to notify the Company in writing that it intends to exercise such preemptive
right and as to the amount of Covered Securities the Qualified Purchaser desires to purchase, up to the maximum amount calculated
pursuant to Section 4.14(a) (the “Designated Securities”). Such notice constitutes a non-binding indication
of interest of such Qualified Purchaser to purchase the amount of Designated Securities specified by such Qualified Purchaser
(or a proportionately lesser amount if the amount of Covered Securities to be offered in such Qualified Offering is subsequently
reduced) at the price (or range of prices) established in the Qualified Offering and other terms set forth in the Company’s
notice to it. The failure to respond during the Offer Period constitutes a waiver of such Qualified Purchaser’s preemptive
right in respect of such offering. The sale of the Covered Securities in the Qualified Offering, including any Designated Securities,
shall be closed not later than 30 days after the end of the Offer Period. The Covered Securities to be sold to other investors
in such Qualified Offering shall be sold at a price not less than, and upon terms no more favorable to such other investors than,
those specified in the Qualified Offering Notice. If the Company does not consummate the sale of Covered Securities to other investors
within such 30-day period, the right provided hereunder shall be revived and such securities shall not be offered unless first
reoffered to the Qualified Purchasers in accordance herewith. Notwithstanding anything to the contrary set forth herein and unless
otherwise agreed by the Qualified Purchasers, by not later than the end of such 30-day period, the Company shall either confirm
in writing to the Qualified Purchasers that the Qualified Offering has been abandoned or shall publicly disclose its intention
to issue the Covered Securities in the Qualified Offering, in either case in such a manner that the Qualified Purchasers will
not be in possession of any material, non-public information thereafter.

    	 	 30	 

     

    

(c)                    
If a Qualified Purchaser exercises its preemptive right provided in this Section 4.14 with respect to a Qualified Offering
that is an underwritten public offering or an offering made to qualified institutional buyers (as such term is defined in SEC
Rule 144A under the Securities Act) for resale pursuant to Rule 144A under the Securities Act (a “Rule 144A Offering”),
a private placement or other offering, whether or not registered under the Securities Act, the Company shall offer and sell
such Qualified Purchaser, if any such offering is consummated, the Designated Securities (as adjusted, upward to reflect the actual
size of such offering when priced) at the same price as the Covered Securities are offered to third persons (not including the
underwriters or the initial purchasers in a Rule 144A Offering that is being reoffered by the initial purchasers) in such offering
and shall provide written notice of such price upon the determination of such price.

(d)                    
In addition to the pricing provision of Section 4.14(c), the Company will offer and sell the Designated Securities to each
Qualified Purchaser upon terms and conditions not less favorable than the most favorable terms and conditions offered to other
persons or entities in a Qualified Offering.

 

(e)                     
In the case of the offering of securities for a consideration in whole or in part other than cash, including securities
acquired in exchange therefor (other than securities by their terms so exchangeable), the consideration other than cash shall
be deemed to be the fair value thereof as determined by the Board; provided, however, that such fair value as determined
by the Board shall not exceed the aggregate market price of the securities being offered as of the date the Board authorizes the
offering of such securities.

(f)                      
The Company and each Qualified Purchaser shall cooperate in good faith to facilitate the exercise of such Qualified Purchaser’s
rights under this Section 4.14, including to secure any required approvals or consents.

 

    	 	 31	 

     

    

4.15                
Most Favored Nation. During the period from the date of this Agreement through the Closing Date, the Company nor
the Bank shall enter into any additional, or modify any existing, agreements with any existing or future investors in the Company
or the Bartle that have the effect of establishing rights or otherwise benefiting such investor in a manner more favorable in
any material respect to such investor than the rights and benefits established in favor of the Purchasers by this Agreement, unless,
in any such case, the Purchasers have been provided with such rights and benefits.

 

ARTICLE
V

CONDITIONS
PRECEDENT TO CLOSING

 

5.1                  
Conditions Precedent to the Obligations of the Purchasers to Purchase Shares. The obligation of each Purchaser to
acquire Shares at the Closing is subject to the fulfillment to such Purchaser’s satisfaction, on or prior to the Closing
Date, of each of the following conditions, any of which may be waived by such Purchaser (as to itself only):

 

(a)                   
Representations and Warranties. The representations and warranties of the Company contained herein shall be true
and correct as of the date when made and as of the Closing Date, as though made on and as of such date, except for such representations
and warranties that speak as of a specific date.

 

(b)                   
Performance. The Company shall have performed, satisfied and complied in all material respects with all covenants,
agreements and conditions required by the Transaction Documents to be performed, satisfied or complied with by it at or prior
to the Closing.

 

(c)                   
No Injunction. No statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted,
entered, promulgated or endorsed by any court or governmental authority of competent jurisdiction, nor shall there have been any
regulatory communication, that prohibits the consummation of any of the transactions contemplated by the Transaction Documents.

 

(d)                  
Consents. The Company shall have obtained in a timely fashion any and all consents, permits, approvals, registrations
and waivers necessary for consummation of the purchase and sale of the Shares, all of which shall be and remain so long as necessary
in full force and effect. 

(e)                   
No Suspensions of Trading in Common Stock; Listing. The Common Stock (i) shall be designated for listing and quotation
on the Principal Trading Market and (ii) shall not have been suspended, as of the Closing Date, by the Commission or the Principal
Trading Market from trading on the Principal Trading Market nor shall suspension by the Commission or the Principal Trading Market
have been threatened, as of the Closing Date, either (A) in writing by the Commission or the Principal Trading Market or (B) by
falling below the minimum listing maintenance requirements of the Principal Trading Market.

 

(f)                     
Company Deliverables. The Company shall have delivered the Company Deliverables in accordance with Section 2.2(a).

 

    	 	 32	 

     

    

(g)                   
Minimum Gross Proceeds. The Company shall issue and sell pursuant to this Agreement and the Additional Agreements
at least 1,000,000 shares of Common Stock at a price per share equal to the Purchase Price, and shall simultaneously issue and
deliver such shares at the Closing to the Purchasers hereunder and the Additional Investors under the Additional Agreements.

(h)                   
Termination. This Agreement shall not have been terminated as to such Purchaser in accordance with Section 6.16
herein.

(i)                      
Bank Regulatory Issues. The purchase of such Shares by such Purchaser shall not (i) cause such Purchaser or any
of its Affiliates to violate any banking regulation, (ii) require such Purchaser or any of its Affiliates to file a prior notice
with the Federal Reserve or its delegee under the CIBC Act or the BHC Act or obtain the prior approval of any banking regulator,
(iii) require such Purchaser or any of its affiliates to become a bank holding company or otherwise serve as a source of strength
for the Company or the Bank or (iv) cause such Purchaser, together with any other person whose Company securities would be aggregated
with such Purchaser’s Company securities for purposes of any banking regulation or law, to collectively be deemed to own,
control or have the power to vote securities which (assuming, for this purpose only, full conversion and/or exercise of such securities
by the Purchaser and such other Persons) would represent more than 9.9% of any class of voting securities of the Company outstanding
at such time.

(j)       No
Burdensome Condition. Since the date hereof, there shall not be any action taken, or any law, rule or regulation enacted,
entered, enforced or deemed applicable to the Company or the Bank, such Purchaser (or its Affiliates) or the transactions contemplated
by this Agreement, by any bank regulatory authority which imposes any restriction or condition on the Company or its Subsidiaries
or such Purchaser or any of its Affiliates (other than such restrictions as are described in any passivity or anti-association
commitments, as may be amended from time to time, entered into by such Purchaser) which such Purchaser determines, in its reasonable
good faith judgment, is materially and unreasonably burdensome on the Company’s business following the Closing or on such
Purchaser (or any of its Affiliates) or would reduce the economic benefits of the transactions contemplated by this Agreement
to such Purchaser to such a degree that such Purchaser would not have entered into this Agreement had such condition or restriction
been known to it on the date hereof (any such condition or restriction, a “Burdensome Condition”), and, for
the avoidance of doubt, any requirements to disclose the identities of limited partners, shareholders or non-managing members
of such Purchaser or its Affiliates or its investment advisers shall be deemed a Burdensome Condition unless otherwise determined
by such Purchaser in its sole discretion.

 

(k)       Material
Adverse Effect. No Material Adverse Effect shall have occurred since the date of this Agreement.

5.2                    
Conditions Precedent to the Obligations of the Company to sell Shares. The Company’s obligation to sell and
issue the Shares to each Purchaser at the Closing is subject to the fulfillment to the satisfaction of the Company on or prior
to the Closing Date of the following conditions, any of which may be waived by the Company:

 

    	 	 33	 

     

    

(a)                   
Representations and Warranties. The representations and warranties made by such Purchaser in Section 3.2 hereof
shall be true and correct as of the date when made, and as of the Closing Date as though made on and as of such date, except for
representations and warranties that speak as of a specific date.

 

(b)                  
Performance. Such Purchaser shall have performed, satisfied and complied in all material respects with all covenants,
agreements and conditions required by the Transaction Documents to be performed, satisfied or complied with by such Purchaser
at or prior to the Closing Date.

 

(c)                   
No Injunction. No statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted,
entered, promulgated or endorsed by any court or governmental authority of competent jurisdiction, nor shall there have been any
regulatory communication, that prohibits the consummation of any of the transactions contemplated by the Transaction Documents.

 

(d)                   
Purchasers Deliverables. Such Purchaser shall have delivered its Purchaser Deliverables in accordance with Section
2.2(b).

 

(e)                   
Termination. This Agreement shall not have been terminated as to such Purchaser in accordance with Section 6.16
herein.

 

(f)                    
Bank Regulatory Issues. The purchase of such Shares by such Purchaser shall not (i) cause such Purchaser or any
of its Affiliates to violate any banking regulation, (ii) require such Purchaser or any of its Affiliates to file a prior notice
with the Federal Reserve or its delegee under the CIBC Act or the BHC Act or obtain the prior approval of any banking regulator,
(iii) require such Purchaser or any of its affiliates to become a bank holding company or otherwise serve as a source of strength
for the Company or the Bank or (iv) cause such Purchaser, together with any other person whose Company securities would be aggregated
with such Purchaser’s Company securities for purposes of any banking regulation or law, to collectively be deemed to own,
control or have the power to vote securities which (assuming, for this purpose only, full conversion and/or exercise of such securities
by the Purchaser and such other Persons) would represent more than 9.9% of any class of voting securities of the Company outstanding
at such time.

 

ARTICLE
VI MISCELLANEOUS

 

6.1                  
Fees and Expenses. The Company shall pay the reasonable legal fees and expenses of Greenberg Traurig, LLP, counsel
to certain Purchasers, incurred by such Purchasers in connection with the transactions contemplated by the Transaction Documents,
up to a maximum amount of $40,000, which amount shall be paid directly by the Company to Greenberg Traurig, LLP at the Closing
or paid by the Company to Greenberg Traurig, LLP upon termination of this Agreement so long as such termination did not occur
as a result of a material breach by such Purchasers of any of their obligations hereunder (as the case may be). Except as set
forth above or elsewhere in the Transaction Documents, the parties hereto shall be responsible for the payment of all expenses
incurred by them in connection with the preparation and negotiation of the Transaction Documents and the consummation of the transactions
contemplated hereby. The Company shall pay all amounts owed to the Placement Agent relating to or arising out of the transactions
contemplated hereby. The Company shall pay all Transfer Agent fees, stamp taxes and other taxes and duties levied in connection
with the sale and issuance of the Shares to the Purchasers.

 

    	 	 34	 

     

    

6.2                   
Entire Agreement. The Transaction Documents, together with the exhibits and schedules thereto, contain the entire
understanding of the parties with respect to the subject matter hereof and supersede all prior agreements, understandings, discussions
and representations, oral or written, with respect to such matters, which the parties acknowledge have been merged into such documents,
exhibits and schedules. At or after the Closing, and without further consideration, the Company and the Purchasers will execute
and deliver to the other such further documents as may be reasonably requested in order to give practical effect to the intention
of the parties under the Transaction Documents.

6.3                   
Notices. Any and all notices or other communications or deliveries required or permitted to be provided hereunder
shall be in writing and shall be deemed given and effective on the earliest of (a) the date of transmission, if such notice or
communication is delivered via facsimile or e-mail (provided the sender receives a machine-generated confirmation of successful
facsimile transmission or e-mail notification or confirmation of receipt of an e-mail transmission) at the facsimile number or
e-mail address specified in this Section prior to 5:00 p.m., New York City time, on a Trading Day, (b) the next Trading Day after
the date of transmission, if such notice or communication is delivered via facsimile at the facsimile number specified in this
Section on a day that is not a Trading Day or later than 5:00 p.m., New York City time, on any Trading Day, (c) the Trading Day
following the date of mailing, if sent by U.S. nationally recognized overnight courier service with next day delivery specified,
or (d) upon actual receipt by the party to whom such notice is required to be given. The address for such notices and communications
shall be as follows:

 

	 	If
    to the Company:	GrandSouth
    Bancorporation
	 	 	381
    Halton Road
	 	 	Greenville,
    SC 29607
	 	 	Attention:
    J.B. Garrett, CFO 
	 	 	Telephone:
    (864) 770-1000
	 	 	E-Mail:
    jb.garrett@grandsouth.com
	 	 	 
	 	 	 
	 	With
    a copy to:	Haynsworth
    Sinkler Boyd, P.A.
	 	 	1201
    Main Street, 22nd Floor (29201-3226)
	 	 	P.O.
    Box 11889 (29211-1889)
	 	 	Columbia,
    SC
	 	 	Attention:
    George S. King, Jr., Esq. 
	 	 	Telephone:
    (803) 540-7818
	 	 	Fax:
    (803) 765-1243
	 	 	E-Mail:
    GK.ing@hsblawfirm.com
	 	 	 
	 	If
    to a Purchaser:	To
    the address set forth under such Purchaser’s name on the signature page hereof;

 

or
such other address as may be designated in writing hereafter, in the same manner, by such Person.

 

    	 	 35	 

     

    

6.4                  
Amendments; Waivers; No Additional Consideration. No amendment or waiver of any provision of this Agreement will
be effective with respect to any party unless made in writing and signed by an officer or a duly authorized representative of
such party. No consideration shall be offered or paid to any Purchaser to amend or consent to a waiver or modification of any
provision of any Transaction Document unless the same consideration is also offered to all Purchasers who then hold Shares.

 

6.5                 
Construction. The headings herein are for convenience only, do not constitute a part of this Agreement and shall
not be deemed to limit or affect any of the provisions hereof. The language used in this Agreement will be deemed to be the language
chosen by the parties to express their mutual intent, and no rules of strict construction will be applied against any party. This
Agreement shall be construed as if drafted jointly by the parties, and no presumption or burden of proof shall arise favoring
or disfavoring any party by virtue of the authorship of any provisions of this Agreement or any of the Transaction Documents.

 

6.6                 
Successors and Assigns. The provisions of this Agreement shall inure to the benefit of and be binding upon the parties
and their successors and permitted assigns. This Agreement, or any rights or obligations hereunder, may not be assigned by the
Company without the prior written consent of the Purchasers. Any Purchaser may assign its rights hereunder in whole or in part
to any Person to whom such Purchaser assigns or transfers any Shares in compliance with the Transaction Documents and applicable
law, provided that such transferee shall agree in writing to be bound, with respect to the transferred Shares, by the terms and
conditions of this Agreement that apply to the “Purchasers”.

 

6.7                 
No Third-Party Beneficiaries. This Agreement is intended for the benefit of the parties hereto and their respective
successors and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person,
other than Indemnified Persons.

 

6.8                 
Governing Law. This Agreement will be governed by and construed in accordance with the laws of the State of
New York applicable to contracts made and to be performed entirely within such State. Each party agrees that all Proceedings concerning
the interpretations, enforcement and defense of the transactions contemplated by this Agreement and any other Transaction Documents
(whether brought against a party hereto or its respective Affiliates, employees or agents) may be commenced on a non-exclusive
basis in the New York Courts. Each party hereto hereby irrevocably submits to the non-exclusive jurisdiction of the New York Courts
for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed
herein (including with respect to the enforcement of any of the Transaction Documents), and hereby irrevocably waives, and agrees
not to assert in any Proceeding, any claim that it is not personally subject to the jurisdiction of any such New York Court, or
that such Proceeding has been commenced in an improper or inconvenient forum. Each party hereto hereby irrevocably waives personal
service of process and consents to process being served in any such Proceeding by mailing a copy thereof via registered or certified
mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement
and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein
shall be deemed to limit in any way any right to serve process in any manner permitted by law. EACH PARTY HERETO HEREBY IRREVOCABLY
WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING
OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY.

 

    	 	 36	 

     

    

6.9                  
Survival. Subject to applicable statute of limitations, the representations, warranties, agreements and covenants
contained herein shall survive the Closing and the delivery of the Shares.

6.10               
Execution. This Agreement may be executed in two or more counterparts, all of which when taken together shall be
considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered
to the other party, it being understood that the parties need not sign the same counterpart. In the event that any signature is
delivered by facsimile transmission, or by e-mail delivery of a “.pdf’ format data file, such signature shall create
a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and
effect as if such facsimile signature page were an original thereof.

6.11               
Severability. If any provision of this Agreement is held to be invalid or unenforceable in any respect, the validity
and enforceability of the remaining terms and provisions of this Agreement shall not in any way be affected or impaired thereby
and the parties will attempt to agree upon a valid and enforceable provision that is a reasonable substitute therefor, and upon
so agreeing, shall incorporate such substitute provision in this Agreement.

 

6.12               
Replacement of Shares. If any certificate or instrument evidencing any Shares is mutilated, lost, stolen or destroyed,
the Company shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof, or in lieu of and
substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to the Company
and the Transfer Agent of such loss, theft or destruction and the execution by the holder thereof of a customary lost certificate
affidavit of that fact and an agreement to indemnify and hold harmless the Company and the Transfer Agent for any losses in connection
therewith or, if required by the Transfer Agent, a bond in such form and amount as is required by the Transfer Agent. The applicants
for a new certificate or instrument under such circumstances shall also pay any reasonable third-party costs associated with the
issuance of such replacement Shares. If a replacement certificate or instrument evidencing any Shares is requested due to a mutilation
thereof, the Company may require delivery of such mutilated certificate or instrument as a condition precedent to any issuance
of a replacement.

 

6.13                
Remedies. In addition to being entitled to exercise all rights provided herein or granted by law, including recovery
of damages, each of the Purchasers and the Company may be entitled to specific performance under the Transaction Documents. The
parties agree that monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations
described in the foregoing sentence and hereby agree to waive in any action for specific performance of any such obligation (other
than in connection with any action for a temporary restraining order) the defense that a remedy at law would be adequate.

 

    	 	 37	 

     

    

6.14              
Payment Set Aside. To the extent that the Company makes a payment or payments to any Purchaser pursuant to any Transaction
Document or a Purchaser enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement
or exercise or any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered
from, disgorged by or are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other
Person under any law (including, without limitation, any bankruptcy law, state or federal law, common law or equitable cause of
action), then to the extent of any such restoration the obligation or part thereof originally intended to be satisfied shall be
revived and continued in full force and effect as if such payment had not been made or such enforcement or setoff had not occurred.

 

6.15             
Independent Nature of Purchasers’ Obligations and Rights. The obligations of each Purchaser under any Transaction
Document are several and not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way
for the performance of the obligations of any other Purchaser under any Transaction Document. The decision of each Purchaser to
purchase Shares pursuant to the Transaction Documents has been made by such Purchaser independently of any other Purchaser and
independently of any information, materials, statements or opinions as to the business, affairs, operations, assets, properties,
liabilities, results of operations, condition (financial or otherwise) or prospects of the Company or any Subsidiary which may
have been made or given by any other Purchaser or by any agent or employee of any other Purchaser, and no Purchaser and none of
its agents or employees shall have any liability to any other Purchaser (or any other Person) relating to or arising from any
such information, materials, statements or opinions. Nothing contained herein or in any other Transaction Document, and no action
taken by any Purchaser pursuant hereto or thereto, shall be deemed to constitute the Purchasers as a partnership, an association,
a joint venture or any other kind of entity, or create a presumption that the Purchasers are in any way acting in concert or as
a group with respect to such obligations or the transactions contemplated by the Transaction Documents. Each Purchaser acknowledges
that no other Purchaser has acted as agent for such Purchaser in connection with making its investment hereunder and that no Purchaser
will be acting as agent of such Purchaser in connection with monitoring its investment in the Shares or enforcing its rights under
the Transaction Documents. Each Purchaser shall be entitled to independently protect and enforce its rights, including without
limitation the rights arising out of this Agreement or out of the other Transaction Documents, and it shall not be necessary for
any other Purchaser to be joined as an additional party in any Proceeding for such purpose. It is expressly understood and agreed
that each provision contained in this Agreement is between the Company and a Purchaser, solely, and not between the Company and
the Purchasers collectively and not between and among the Purchasers.

 

    	 	 38	 

     

    

6.16             
Termination. This Agreement may be terminated and the sale and purchase of the Shares abandoned at any time prior
to the Closing by either the Company or any Purchaser (with respect to itself only) upon written notice to the other, if the Closing
has not been consummated on or prior to 5:00 p.m., New York City time, on the Outside Date; provided, however, that the
right to terminate this Agreement under this Section 6.16 shall not be available to any Person whose failure to comply with its
obligations under this Agreement has been the cause of or resulted in the failure of the Closing to occur on or before such time.
The Company shall give prompt notice of any such termination to each other Purchaser, and, as necessary, work in good faith to
restructure the transaction to allow each Purchaser that does not exercise a termination right to purchase the full number of
securities set forth below such Purchaser’s name on the signature page of this Agreement while remaining in compliance with
Section 4.11. Nothing in this Section 6.16 shall be deemed to release any party from any liability for any breach by such party
of the terms and provisions of this Agreement or the other Transaction Documents or to impair the right of any party to compel
specific performance by any other party of its obligations under this Agreement or the other Transaction Documents. In the event
of a termination pursuant to this Section, the Company shall promptly notify all non-terminating Purchasers. Upon a termination
in accordance with this Section, the Company and the terminating Purchaser(s) shall not have any further obligation or liability
(including arising from such termination) to the other, and no Purchaser will have any liability to any other Purchaser under
the Transaction Documents as a result therefrom.

 

6.17               
Rescission and Withdrawal Right. Notwithstanding anything to the contrary contained in (and without limiting any
similar provisions of) the Transaction Documents, whenever any Purchaser exercises a right, election, demand or option under a
Transaction Document and the Company does not timely perform its related obligations within the periods therein provided, then
such Purchaser may rescind or withdraw, in its sole discretion from time to time upon written notice to the Company, any relevant
notice, demand or election in whole or in part without prejudice to its future actions and rights.

 

6.18               
Adjustments in Common Stock Numbers and Prices. In the event of any stock split, subdivision, dividend or distribution
payable in shares of Common Stock (or other securities or rights convertible into, or entitling the holder thereof to receive
directly or indirectly shares of Common Stock), combination or other similar recapitalization or event occurring after the date
hereof and prior to the Closing, each reference in any Transaction Document to a number of shares or a price per share shall be
deemed to be amended to appropriately account for such event.

 

 

[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK]

[SIGNATURE
PAGE FOR COMPANY FOLLOWS]

 

    	 	 39	 

     

    

IN
WITNESS WHEREOF, the parties hereto have caused this Securities purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above.

 

 

	 	GRANDSOUTH BANCORPORATION
	 	 
	 	By: /s/ Mason Y. Garrett
	 	Name: Mason
    Y. Garrett
	 	Title: Chief Executive Officer

 

 

    	 	 40	 

     

    

Purchasers
under that certain Securities Purchase Agreement dated February 3, 2016 with GrandSouth Bancorporation:

 

	 	1.	JCSD
    Capital LLC
	 	 	1676 N. California Blvd.,
    Suite 
	 	 	630 Walnut Creek, CA 94596
	 	 	 
	 	2.	lthan
    Creek Master Investors (Cayman) L.P. 
	 	 	280 Congress
    Street
	 	 	Boston, MA 00210
	 	 	 
	 	3.	Banc
    Fund VII L.P. and Banc Fund IX, L.P. 
	 	 	20 N.
    Wacker Drive, Suite 3300
	 	 	Chicago, IL 60606

 

    	 	 41

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00325-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00325-of-00352.parquet"}]]